Haemophilus influenzae (DSM 24049, ATCC 49247, CCUG 26214)
BacDive ID
11705
Type strain
Strain Designation
TD-4
NCBI tax ID(s)
727
History
DSMZ <- CCUG; CCUG 26214 <- ATCC; ATCC 49247 <- G. V. Doern; TD-4
CIP <- 1995, ATCC <- G.V. Doern: strain TD-4
Links
Haemophilus influenzae TD-4 is a microaerophile, Gram-negative, rod-shaped bacterium that was isolated from human sputum, pneumonia patient.
Gram-negative rod-shaped microaerophile genome sequence BacteriaName and taxonomic classification
SI-ID 2985
LMG 11197,ATCC 49247,CCUG 26214,CIP 104604,DSM 9999,NCTC 12699,CCM 4456,CNCTC 5063,BCRC 17028,CCRC 17028,ACM 5054,DSM 24049
| @ref 20215 |
|
Last LPSN update
2026-05-29 08:27:37 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pasteurellales |
| Family Pasteurellaceae |
| Genus Haemophilus |
| Species Haemophilus influenzae |
| Full scientific name Haemophilus influenzae corrig. (Lehmann and Neumann 1896) Winslow et al. 1917 (Approved Lists 1980) |
| Synonyms (2) |
Culture and growth conditions
Culture medium
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 17317 | HAEMOPHILUS MEDIUM (DSMZ Medium 804) | Medium recipe at MediaDive  | Name: HAEMOPHILUS MEDIUM (DSMZ Medium 804) Composition: Mueller-Hinton broth 21.0 g/l Yeast extract 5.0 g/l Distilled water | ||
| 39696 | MEDIUM 10 - Chocolate medium for Actinobacillus pleuropneumoniae, Capnocytophaga cynodegmi, Haemophilus and Neisseria | Distilled water make up to (1000.000 ml);Columbia agar (39.000 g);Horseblood (100.000 ml);PolyVitex mischung (10.000 ml) | |||
| 120109 | CIP Medium 10 | Medium recipe at CIP |
Physiology and metabolism
Oxygen tolerance
Antibiotic susceptibility testing
| Test 1 | Test 2 | Test 3 | Test 4 | Test 5 | |
|---|---|---|---|---|---|
| @ref | 17317 | 17317 | 17317 | 17317 | 17317 |
| Medium | M 804 | M 804 | M 804 | M 804 | M 804 |
| Manual annotation | 1 | 1 | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 20-22 | 24-26 | 22-24 | 20 | 16 |
| Ampicillin 10µg (disc) | 20 | 20-22 | 22 | 20 | 18 |
| Aztreonam 30µg (disc) | 36 | 40 | 38 | 34 | 36-38 |
| Bacitracin 10Unit | 0 | 0 | 0 | 0 | n.d. |
| Cefalotin 30µg (disc) | 12-14 | 26-28 | 24-26 | 10 | n.d. |
| Cefazolin 30µg (disc) | 22 | 24 | 26 | 16-18 | n.d. |
| Cefiderocol 30µg (disc) | n.d. | n.d. | n.d. | n.d. | 24-26 |
| Cefotaxime 30µg (disc) | 34-36 | 38-40 | 38 | 36 | 34 |
| Ceftazidime 10µg (disc) | n.d. | n.d. | n.d. | n.d. | 28-30 |
| Ceftriaxone 30µg (disc) | 34-36 | 38-40 | 40 | 36 | 34 |
| Chloramphenicol 30µg (disc) | 40 | 40 | 40 | 34 | 32-34 |
| Ciprofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | 40 |
| Clindamycin 10µg (disc) | 18 | 20 | 18 | 8 | 0 |
| Colistin 10µg (disc) | 18 | 18 | 18 | 16 | n.d. |
| Colistin sulphate 10µg (disc) | n.d. | n.d. | n.d. | n.d. | 16-18 |
| Doxycycline 30µg (disc) | 24 | 24 | 24-26 | 22 | n.d. |
| Erythromycin 15µg (disc) | 16 | 20 | 18 | 16-18 | 12-14 |
| Fosfomycin 50µg (disc) | 42 | 48-50 | 50 | 32 | 30 |
| Gentamicin 10µg (disc) | 20 | 22 | 20 | 18 | n.d. |
| Gentamicin 30µg (disc) | n.d. | n.d. | n.d. | n.d. | 18-20 |
| Imipenem 10µg (disc) | 28 | 30 | 32 | 28 | 28 |
| Kanamycin 30µg (disc) | 22 | 26 | 24 | 22 | 20 |
| Levofloxacin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | 40 |
| Lincomycin 15µg (disc) | 12 | 16 | 12-14 | 10 | n.d. |
| Linezolid 10µg (disc) | 22 | 26 | 16-18 | 20 | 18 |
| Meropenem 10µg (disc) | n.d. | n.d. | n.d. | n.d. | 30-32 |
| Mezlocillin 30µg (disc) | 32 | 34 | 32 | 30 | n.d. |
| Moxifloxacin 5µg (disc) | 34-36 | 38-40 | 40 | 36-38 | 30 |
| Neomycin 30µg (disc) | 16 | 18 | 18-20 | 16-18 | n.d. |
| Nitrofurantoin 100µg (disc) | 30 | 34-36 | 32 | 24-26 | 22 |
| Norfloxacin 10µg (disc) | 38-40 | 38-40 | 38 | 36-38 | n.d. |
| Nystatin 100Unit | 0 | 0 | 8 | 0 | n.d. |
| Ofloxacin 5µg (disc) | 38 | 40 | 40 | 36 | 34-36 |
| Oxacillin 5µg (disc) | 0 | 0 | 0 | 0 | 0 |
| Penicillin G 6µg (disc) | 14 | 16 | 16 | 12 | 16 |
| Pipemidic acid 20µg (disc) | 26 | 28 | 24-26 | 24 | n.d. |
| Piperacillin/Tazobactam 40µg (disc) | 36 | 38 | 38 | 34 | n.d. |
| Piperacillin/Tazobactam 110µg (disc) | n.d. | n.d. | n.d. | n.d. | 38-40 |
| Polymyxin B 300Unit | 20 | 20 | 18 | 16 | 18-20 |
| Quinupristin/Dalfopristin 15µg (disc) | 20 | 20 | 20-22 | 16-18 | 16-18 |
| Rifampicin 5µg (disc) | n.d. | n.d. | n.d. | n.d. | 22 |
| Teicoplanin 30µg (disc) | 10 | 10 | 10 | 6-8 | 10 |
| Tetracycline 30µg (disc) | 20 | 20 | 20 | 18 | 18 |
| Ticarcillin 75µg (disc) | 32 | 34 | 32-34 | 30-32 | 30 |
| Tigecycline 15µg (disc) | n.d. | n.d. | n.d. | n.d. | 24-26 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | n.d. | n.d. | n.d. | n.d. | 26-28 |
| Vancomycin 30µg (disc) | 0 | 0 | 0 | 0 | 0 |
Metabolite utilization
Antibiotic resistance
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 17317 | 28669 | Bacitracin | 10 Unit | from Antibiotic test | |
| 17317 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 17317 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
Enzymes
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 120109 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 120109 | beta-galactosidase | - | 3.2.1.23 | |
| 68377 | beta-galactosidase | - | 3.2.1.23 | from API NH |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 17317 | catalase | + | 1.11.1.6 | |
| 120109 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 17317 | cytochrome-c oxidase | + | 1.9.3.1 | |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 120109 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 120109 | lysine decarboxylase | + | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 120109 | ornithine decarboxylase | + | 4.1.1.17 | |
| 120109 | oxidase | + | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 120109 | urease | + | 3.5.1.5 | |
| 68382 | valine arylamidase | - | from API zym |
Fatty acid profile
Metadata FA analysis  | |||||||||||||||||||||||||||||||
| @ref | 48391 | ||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
API zym
API NH
| @ref | PEN | GLU | FRU | MAL | SAC | ODC | URE | LIP | PAL | beta GAL | ProA | GGT | IND | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17317 | + | + | - | +/- | + | + | - | + | - | - | - | + | - | |
| 17317 | + | + | - | + | + | + | - | + | - | - | + | + | - | |
| 17317 | + | + | - | - | + | + | - | + | - | - | - | + | - | |
| 17317 | - | + | + | - | - | + | + | - | + | - | - | +/- | + | |
| 17317 | - | + | + | +/- | +/- | + | + | - | + | - | - | + | + | |
| 17317 | - | + | + | - | - | + | + | - | + | - | - | - | + | |
| 17317 | - | + | + | - | + | + | + | - | + | - | - | + | + | |
| 17317 | - | + | + | - | +/- | + | + | - | + | - | - | - | + | |
| 17317 | - | + | + | - | - | - | + | - | + | - | - | - | + |
API biotype100
Sequence information
Genome sequences
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | 34211_C02 assembly for Haemophilus influenzae NCTC12699 | complete | GCA_900635805   | 727.1824  | 727 | 98.5 | | |
| 66792 | ASM167923v1 assembly for Haemophilus influenzae CCUG 26214 | scaffold | GCA_001679235 | 727.965 | 8004500539  | 727 | 73.71 | |
Genome browser: GCA_900635805
Literature
Literature 
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Integrated transcriptomics and metabolomics study on the biofilm formation of Haemophilus influenzae by the stimulation of amoxicillin-clavulanate at subinhibitory concentration. | Xiao J, Su L, Huang S, Zhou M, Chen Z. | Microb Pathog | 10.1016/j.micpath.2025.107650 | 2025 | | |
| Shifts in Epidemiology and Antibiotic Resistance of Haemophilus Influenzae in Children From Chongqing (2019-2024): Pre-, During, and Post-COVID-19. | Wang J, Wang R, Jing C, Xiang Y, Xiong Z, Liu F. | Infect Drug Resist | 10.2147/idr.s535755 | 2025 | | |
| Methodological establishment and diagnostic value of a multiplex fluorescent PCR assay for the detection of three fastidious respiratory pathogens. | Shi J, Zhu Y, Chen S, Shan X, Bo L, Shen K, Chen K. | PLoS One | 10.1371/journal.pone.0328651 | 2025 | | |
| Characteristics of 241 invasive and non-invasive Haemophilus influenzae isolated from patients under 14 years old, Hebei Province, China. | Che J, Zhang HB, Guo YH, Jia ZY, He BH, Chen BH, Shao ZJ, Sun YQ, Li Q. | BMC Infect Dis | 10.1186/s12879-025-11396-2 | 2025 | | |
| Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae | Cao Y, Wang J, Jiang Y, Xu L, Tian Y, Fan Z, Pan Z, Mo Y, Zhu X, Zhang X, Huang J, Ren F. | Front Cell Infect Microbiol | 2025 | | ||
| Comparative Effects of Cigarette Smoke and Heated Tobacco Product Aerosols on Biofilm Production by Respiratory Pathogens. | Schiopu P, Toc DA, Colosi IA, Costache C, Panaitescu PS, Neculicioiu VS, Gorcea CM, Zagarin TI, Murarasu AR, Todea DA. | Microorganisms | 10.3390/microorganisms13112459 | 2025 | | |
| The lack of specificity of sodC-based PCR for the detection of Neisseria meningitidis carriage in pharyngeal swabs from adolescents. | Pham-Tran DD, Leong LEX, McMillan M, Lawrence A, Mohammed H, Finn A, Marshall HS. | Microbiol Spectr | 10.1128/spectrum.02779-24 | 2025 | | |
| Amino acid substitutions in PBP3 in Haemophilus influenzae strains, their phenotypic detection and impact on resistance to beta-lactams. | Jakubu V, Cechova M, Musilek M, Malisova L, Zapletalova B, Zemlickova H. | J Antimicrob Chemother | 10.1093/jac/dkaf023 | 2025 | | |
| Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. | Torumkuney D, Nizamuddin S, Morrissey I, Manenzhe R, Manoharan A. | J Antimicrob Chemother | 10.1093/jac/dkaf288 | 2025 | | |
| Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. | Torumkuney D, Bratus E, Yuvko O, Pertseva T, Morrissey I, Beltrame CO, Manoharan A. | J Antimicrob Chemother | 10.1093/jac/dkaf287 | 2025 | | |
| Haemophilus influenzae Invasive Infections in Children in Vaccine Era: Phenotypic and Genotypic Characterization Tunis, Tunisia. | Chelbi Y, Meftah K, Deghmane AE, Mhimdi S, Aloui F, Bouafsoun A, Hong E, Menif K, Boussetta K, Khemiri M, Boukthir S, Trifa M, Jlidi S, Jouini R, Fitouri Z, Nessib MN, Taha MK, Smaoui H. | Microorganisms | 10.3390/microorganisms12122666 | 2024 | | |
| Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in India: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. | Torumkuney D, Veeraraghavan B, Patil N, Dias M, Maheshwari G, Chaudhuri BN, Ray U, Hawser S, Kundu S, Manoharan A. | J Antimicrob Chemother | 10.1093/jac/dkaf285 | 2025 | | |
| Genomic profiling of cefotaxime-resistant Haemophilus influenzae from Norway and Sweden reveals extensive expansion of virulent multidrug-resistant international clones | Skaare D, Anthonisen I, Zecic N, Jenkins A, Caugant D, Ranheim T, Sundsfjord A, Hegstad K. | Front Microbiol | 2025 | | ||
| Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Tunisia: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. | Torumkuney D, Slim L, Hammami A, Hawser S, Manenzhe R, Manoharan A. | J Antimicrob Chemother | 10.1093/jac/dkaf286 | 2025 | | |
| Results from the Survey of Antibiotic Resistance (SOAR) 2020-21 in Vietnam: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. | Torumkuney D, Van PH, Thinh LQ, Hawser S, Kundu S, Truong Ha Lan N, Manoharan A. | J Antimicrob Chemother | 10.1093/jac/dkaf290 | 2025 | | |
| Haemophilus influenzae blood-stream infection and third-generation cephalosporin susceptibility testing: a comparative case study using EUCAST and CLSI guidelines. | Merlino J, Rizzo S, English S, Baskar SR, Siarakas S, Mckew G, Fernanado S, Gray T. | Access Microbiol | 10.1099/acmi.0.000578.v4 | 2023 | | |
| Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Türkiye: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. | Torumkuney D, Keles N, Hasdemir U, Hazirolan G, Aydemir S, Aktas Z, Oncul O, Morrissey I, Manoharan A. | J Antimicrob Chemother | 10.1093/jac/dkaf289 | 2025 | | |
| Expanded Gram-Negative Activity of Marinopyrrole A. | Euteneuer CF, Davis BN, Lui LM, Neville AJ, Davis PH. | Pathogens | 10.3390/pathogens14030290 | 2025 | | |
| Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. | Torumkuney D, Canton R, Pitart C, Sanguinetti M, Vismara C, Farina C, Sambri V, Hawser S, Manoharan A. | J Antimicrob Chemother | 10.1093/jac/dkaf283 | 2025 | | |
| Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Kuwait and the United Arab Emirates: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. | Torumkuney D, Mokaddas E, Weber S, Morrissey I, Keles N, Manoharan A. | J Antimicrob Chemother | 10.1093/jac/dkaf284 | 2025 | | |
| Establishment and Clinical Application of a RPA-LFS Assay for Detection of Capsulated and Non-Capsulated Haemophilus influenzae. | Wang Y, Liu A, Fu M, Guo J, Wang L, Zuo X, Ma F. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.878813 | 2022 | | |
| Antibacterial and Mode of Action of Extracts from Endophytic Fungi Derived from Terminalia mantaly, Terminalia catappa, and Cananga odorata. | Mbekou MIK, Dize D, Yimgang VL, Djague F, Toghueo RMK, Sewald N, Lenta BN, Boyom FF. | Biomed Res Int | 10.1155/2021/6697973 | 2021 | | |
| Antimicrobial and Antiradical Activity of Extracts from Leaves of Various Cultivars of Pyrus communis and Pyrus pyrifolia. | Zbikowska B, Kotowska M, Gamian A, Patek K, Matula K, Augustyniak D, Korzekwa K, Sroka Z. | Biomolecules | 10.3390/biom15060821 | 2025 | | |
| Genetics | High Prevalence of Group III-Like Mutations Among BLPACR and First Report of Haemophilus influenzae ST95 Isolated from Blood in China. | Lin J, Wang Y, Lin C, Li R, Wang G. | Infect Drug Resist | 10.2147/idr.s400207 | 2023 | |
| Genetics | Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole. | Su PY, Cheng WH, Ho CH. | BMC Microbiol | 10.1186/s12866-023-02926-6 | 2023 | |
| Serotype Distribution and Antimicrobial Resistance Profile of Haemophilus influenzae Isolated from School Children with Acute Otitis Media. | Safari D, Wahyono DJ, Tafroji W, Darmawan AB, Winarti Y, Kusdaryanto WD, Paramaiswari WT, Pramono H, Pratiwi M, Chamadi MR. | Int J Microbiol | 10.1155/2022/5391291 | 2022 | | |
| Typeable ampicillin-resistant Haemophilus influenzae strains in Tunisian's children. | Mzilem S, Boukhchina S. | Medicine (Baltimore) | 10.1097/md.0000000000030713 | 2022 | | |
| Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions. | Schuetz AN, Ferrell A, Hindler JA, Humphries R, Bobenchik AM. | J Clin Microbiol | 10.1128/jcm.01623-23 | 2025 | | |
| Catalase-encapsulated matrix metalloproteinase-9 responsive nanogels for modulation of inflammatory response and treatment of neutrophilic asthma. | Guo X, Zuo X, Zheng W, Zhao D, Dong C, Zou Z, Shen Y, Xu C, He C, Wang F. | J Nanobiotechnology | 10.1186/s12951-025-03470-3 | 2025 | | |
| Distribution and analysis of the resistance profiles of bacteria isolated from blood cultures in the intensive care unit. | Liu Z, Cai H, Lei J, Zhang X, Yin J, Zhang Y, Yu X, Geng Y. | Front Microbiol | 10.3389/fmicb.2025.1464573 | 2025 | | |
| Identification of antimicrobial resistant bacteria isolated from Hyalomma excavatum and Hyalomma dromedarii infesting camels in Aljouf region, Saudi Arabia. | Almutairi MM, Alouffi A, Damra EM, Alotaibi M, Alkahtani NS, Al Salem WS, Aljasham AT. | Front Vet Sci | 10.3389/fvets.2025.1634753 | 2025 | | |
| Misdiagnosis of non-tuberculous mycobacteria as tuberculous by the GeneXpert MTB/RIF Ultra: Fact or fiction? | Opperman CJ, Ntshangase Z, Gumede M, Singh S, Ghebrekristos Y, Warren R, Goosen W. | S Afr J Infect Dis | 10.4102/sajid.v39i1.576 | 2024 | | |
| Enzymology | Early detection of drug-resistant Streptococcus pneumoniae and Haemophilus influenzae by quantitative flow cytometry. | Sawada T, Katayama M, Takatani S, Ohiro Y. | Sci Rep | 10.1038/s41598-021-82186-4 | 2021 | |
| Nasopharyngeal carriage and antimicrobial susceptibility profile of Haemophilus influenzae among patients infected with HIV in Jakarta, Indonesia. | Safari D, Lestari AN, Khoeri MM, Tafroji W, Giri-Rachman EA, Harimurti K, Kurniati N. | Access Microbiol | 10.1099/acmi.0.000165 | 2020 | | |
| Multicenter Antimicrobial Resistance Surveillance of Clinical Isolates from Major Hospitals - China, 2022. | Guo Y, Ding L, Yang Y, Han R, Yin D, Wu S, Zhu D, Hu F. | China CDC Wkly | 10.46234/ccdcw2023.217 | 2023 | | |
| Advances in Small Molecule Inhibitors Targeting the Bacterial Lipoprotein Transport System (Lol) in Gram-Negative Bacteria. | Song S, Shim SY. | Chem Asian J | 10.1002/asia.202500350 | 2025 | | |
| Molecular epidemiology and antimicrobial resistance of Haemophilus influenzae in Guiyang, Guizhou, China. | Zhou Y, Wang Y, Cheng J, Zhao X, Liang Y, Wu J. | Front Public Health | 10.3389/fpubh.2022.947051 | 2022 | | |
| Genetics | Molecular epidemiology and antibiotic resistance profiles of invasive Haemophilus influenzae from Norway 2017-2021. | Tonnessen R, Garcia I, Debech N, Lindstrom JC, Wester AL, Skaare D. | Front Microbiol | 10.3389/fmicb.2022.973257 | 2022 | |
| Fabrication of a Microfluidic Test Device with a 3D Printer and Its Combination with the Loop Mediated Isothermal Amplification Method to Detect Streptococcus pyogenes. | Kirkoyun Uysal H, Eryildiz M, Demirci M. | Micromachines (Basel) | 10.3390/mi15030365 | 2024 | | |
| Enzymology | Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment In Vitro Infection Model. | VanScoy BD, Lakota EA, Conde H, McCauley J, Friedrich L, Steenbergen JN, Ambrose PG, Bhavnani SM. | Antimicrob Agents Chemother | 10.1128/aac.02265-19 | 2020 | |
| Serovar and multilocus sequence typing analysis of Pasteurella multocida from diseased pigs in Taiwan. | Wu CF, Liao CC, Chou CC, Wang CM, Huang SW, Kuo HC. | BMC Vet Res | 10.1186/s12917-025-04595-1 | 2025 | | |
| Quinolone Resistance Is Transferred Horizontally via Uptake Signal Sequence Recognition in Haemophilus influenzae. | Tanaka E, Wajima T, Uchiya KI, Nakaminami H. | Antimicrob Agents Chemother | 10.1128/aac.01967-21 | 2022 | | |
| In Vitro Anti-NTHi Activity of Haemophilin-Producing Strains of Haemophilus haemolyticus. | Atto B, Latham R, Kunde D, Gell DA, Tristram S. | Pathogens | 10.3390/pathogens9040243 | 2020 | | |
| Prevalence of susceptibility patterns of opportunistic bacteria in line with CLSI or EUCAST among Haemophilus parainfluenzae isolated from respiratory microbiota. | Kosikowska U, Andrzejczuk S, Grywalska E, Chwiejczak E, Winiarczyk S, Pietras-Ozga D, Stepien-Pysniak D. | Sci Rep | 10.1038/s41598-020-68161-5 | 2020 | | |
| Sharp rise in high-virulence Bordetella pertussis with macrolides resistance in Northern China. | Hu Y, Zhou L, Du Q, Shi W, Meng Q, Yuan L, Hu H, Ma L, Li D, Yao K. | Emerg Microbes Infect | 10.1080/22221751.2025.2475841 | 2025 | | |
| Etiology of meningitis among adults in three quaternary hospitals in Mozambique, 2016-2017: The role of HIV. | Nhantumbo AA, Come CE, Maholela PI, Munguambe AM, Costa PD, Mott M, Cunha GR, Chambal L, Dias C, Cantarelli VV, Gudo ES. | PLoS One | 10.1371/journal.pone.0267949 | 2022 | | |
| Mucosal immunity of mannose-modified chitosan microspheres loaded with the nontyepable Haemophilus influenzae outer membrane protein P6 in BALB/c mice. | Ma Y, Zhao Y, Chen R, Sun W, Zhang Y, Qiao H, Chang Y, Kang S, Zhang Y. | PLoS One | 10.1371/journal.pone.0269153 | 2022 | | |
| Pathogenicity | Antimicrobial Activity of Ceftolozane-Tazobactam and Comparators against Clinical Isolates of Haemophilus influenzae from the United States and Europe. | Sader HS, Carvalhaes CG, Duncan LR, Shortridge D. | Antimicrob Agents Chemother | 10.1128/aac.00211-20 | 2020 | |
| Distribution and Antimicrobial Resistance Analysis of Blood Culture Isolates at a Chinese National Cardiovascular Regional Medical Center: A 7-Year Retrospective Study | Wang Q, Wu F, Li T. | Infect Drug Resist | 2025 | | ||
| Multilaboratory Comparison of Omadacycline MIC Test Strip to Broth Microdilution MIC against Gram-Negative, Gram-Positive, and Fastidious Bacteria. | Koeth LK, DiFranco-Fisher JM, Hardy DJ, Palavecino EL, Carretto E, Windau A. | J Clin Microbiol | 10.1128/jcm.01410-21 | 2022 | | |
| Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical Trial. | Ooi N, Cooper IR, Norman B, Gallagher JA, Sireau N, Bou-Gharios G, Ranganath LR, Savage VJ. | Cells | 10.3390/cells12131683 | 2023 | | |
| Characterization of Haemophilus influenzae Strains with Non-Enzymatic Resistance to beta-Lactam Antibiotics Caused by Mutations in the PBP3 Gene in the Czech Republic in 2010-2018. | Jakubu V, Malisova L, Musilek M, Pomorska K, Zemlickova H. | Life (Basel) | 10.3390/life11111260 | 2021 | | |
| Detection of Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae in Culture Negative Cerebrospinal Fluid Samples from Meningitis Patients Using a Multiplex Polymerase Chain Reaction in Nepal. | Sharma S, Acharya J, Caugant DA, Banjara MR, Ghimire P, Singh A. | Infect Dis Rep | 10.3390/idr13010019 | 2021 | | |
| Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19. | Meng Q, Li W, Jiang H, Yan H, Wang H, Ye B, Zhou L, Chen Y. | Infect Dis Ther | 10.1007/s40121-022-00751-4 | 2023 | | |
| Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016. | Potts CC, Rodriguez-Rivera LD, Retchless AC, Buono SA, Chen AT, Marjuki H, Blain AE, Wang X. | Microbiol Spectr | 10.1128/spectrum.02579-21 | 2022 | | |
| Enzymology | Chemical constituents from leaves and trunk bark of Rinorea oblongifolia (Violaceae). | Munvera AM, Ouahouo BMW, Mkounga P, Mbekou MIK, Nuzhat S, Choudhary MI, Nkengfack AE. | Nat Prod Res | 10.1080/14786419.2019.1573230 | 2020 | |
| Recent developments on UDP-N-acetylmuramoyl-L-alanine-D-gutamate ligase (Mur D) enzyme for antimicrobial drug development: An emphasis on in-silico approaches. | Gaur V, Bera S. | Curr Res Pharmacol Drug Discov | 10.1016/j.crphar.2022.100137 | 2022 | | |
| Effects of Structural Manipulation on the Bioactivity of some Coumarin-Based Products. | Fakri Mustafa Y, Riyadh Khalil R, Tareq Mohammed E, Bashir MK, Khudhayer Oglah M. | Arch Razi Inst | 10.22092/ari.2021.356100.1776 | 2021 | | |
| Pathogenicity | Clonal diversity of Haemophilus influenzae carriage isolated from under the age of 6 years children. | Shooraj F, Mirzaei B, Mousavi SF, Hosseini F. | BMC Res Notes | 10.1186/s13104-019-4603-7 | 2019 | |
| Oropharyngeal Carriage of hpl-Containing Haemophilus haemolyticus Predicts Lower Prevalence and Density of NTHi Colonisation in Healthy Adults. | Atto B, Kunde D, Gell DA, Tristram S. | Pathogens | 10.3390/pathogens10050577 | 2021 | | |
| Pathogenicity | Oldenlandia diffusa Extract Inhibits Biofilm Formation by Haemophilus influenzae Clinical Isolates. | Wajima T, Anzai Y, Yamada T, Ikoshi H, Noguchi N. | PLoS One | 10.1371/journal.pone.0167335 | 2016 | |
| Interspecies transfer of the penicillin-binding protein 3-encoding gene ftsI between Haemophilus influenzae and Haemophilus haemolyticus can confer reduced susceptibility to beta-lactam antimicrobial agents. | Sondergaard A, Witherden EA, Norskov-Lauritsen N, Tristram SG. | Antimicrob Agents Chemother | 10.1128/aac.04854-14 | 2015 | | |
| Rapid Detection of Candida tropicalis in Clinical Samples From Different Sources Using RPA-LFS. | Wang L, Xu A, Zhou P, Zhao M, Xu C, Wang Y, Wang K, Wang F, Miao Y, Zhao W, Gao X. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.898186 | 2022 | | |
| Development of Multiplex RT-PCR with Immobilized Primers for Identification of Infectious Human Pneumonia Pathogens. | Lapa SA, Miftakhov RA, Klochikhina ES, Ammur YI, Blagodatskikh SA, Shershov VE, Zasedatelev AS, Chudinov AV. | Mol Biol | 10.1134/s0026893321040063 | 2021 | | |
| Validation of Broth Macrodilution Volatilization Method for Testing of Essential Oils in Liquid and Vapor Phase: Chemical Composition, Cytotoxicity, and Antibacterial Effect of Indian Medicinal Plants against Pneumonia-Causing Pathogens. | Chaure A, Houdkova M, Antih J, Urbanova K, Doskocil I, Naik ML, Patel KS, Kokoska L. | Molecules | 10.3390/molecules28124625 | 2023 | | |
| Isolation, identification and antimicrobial susceptibility of the bacteria isolated from Hyalomma dromedarii infesting camels in Al-Jouf province, Saudi Arabia. | Aljasham AT, Damra EM, Alkahtani NS, Alouffi A, Al Salem WS, Alshabanah AO, Alotaibi M, Tanaka T, Ali A, Almutairi MM. | Front Vet Sci | 10.3389/fvets.2023.1227908 | 2023 | | |
| Pathogenicity | Clarithromycin Resistance Mechanisms of Epidemic beta-Lactamase-Nonproducing Ampicillin-Resistant Haemophilus influenzae Strains in Japan. | Seyama S, Wajima T, Nakaminami H, Noguchi N. | Antimicrob Agents Chemother | 10.1128/aac.00163-16 | 2016 | |
| Pilot Testing of the "Turbidimeter", a Simple, Universal Reader Intended to Complement and Enhance Bacterial Growth Detection in Manual Blood Culture Systems in Low-Resource Settings. | Barbe B, Corsmit E, Jans J, Kaur K, Baets R, Jacobs J, Hardy L. | Diagnostics (Basel) | 10.3390/diagnostics12030615 | 2022 | | |
| Molecular Epidemiology and Antimicrobial Resistance of Haemophilus influenzae in Adult Patients in Shanghai, China. | Li XX, Xiao SZ, Gu FF, He WP, Ni YX, Han LZ. | Front Public Health | 10.3389/fpubh.2020.00095 | 2020 | | |
| New Broth Macrodilution Volatilization Method for Antibacterial Susceptibility Testing of Volatile Agents and Evaluation of Their Toxicity Using Modified MTT Assay In Vitro. | Houdkova M, Chaure A, Doskocil I, Havlik J, Kokoska L. | Molecules | 10.3390/molecules26144179 | 2021 | | |
| Serotypes, virulence factors and multilocus sequence typing of Glaesserella parasuis from diseased pigs in Taiwan. | Wu CF, Hsu CY, Chou CC, Wang CM, Huang SW, Kuo HC. | PeerJ | 10.7717/peerj.15823 | 2023 | | |
| Pathogenicity | Amino Acid Substitution in the Major Multidrug Efflux Transporter Protein AcrB Contributes to Low Susceptibility to Azithromycin in Haemophilus influenzae. | Seyama S, Wajima T, Nakaminami H, Noguchi N. | Antimicrob Agents Chemother | 10.1128/aac.01337-17 | 2017 | |
| Enzymology | Assessing Boron-Pleuromutilin AN11251 for the Development of Antibacterial Agents. | Han MJ, Pan M, Xiao G, Yuan Y, Chen S, Zou Z. | Molecules | 10.3390/molecules28124628 | 2023 | |
| High-Level Quinolone-Resistant Haemophilus haemolyticus in Pediatric Patient with No History of Quinolone Exposure. | Tanaka E, Hirai Y, Wajima T, Ishida Y, Kawamura Y, Nakaminami H. | Emerg Infect Dis | 10.3201/eid2801.210248 | 2022 | | |
| AmiA and AliA peptide ligands are secreted by Klebsiella pneumoniae and inhibit growth of Streptococcus pneumoniae. | Lux J, Holivololona L, San Millan Gutierrez R, Hilty M, Ramette A, Heller M, Hathaway LJ. | Sci Rep | 10.1038/s41598-022-26838-z | 2022 | | |
| A Thermostabilized, One-Step PCR Assay for Simultaneous Detection of Klebsiella pneumoniae and Haemophilus influenzae. | Khazani NA, Noor NZ, Yean Yean C, Hasan H, Suraiya S, Mohamad S. | J Trop Med | 10.1155/2017/7210849 | 2017 | | |
| Exploration of Antibiotic Activity of Aminoglycosides, in Particular Ribostamycin Alone and in Combination With Ethylenediaminetetraacetic Acid Against Pathogenic Bacteria. | Kong J, Wu ZX, Wei L, Chen ZS, Yoganathan S. | Front Microbiol | 10.3389/fmicb.2020.01718 | 2020 | | |
| Pathogenicity | Ceftaroline activity on certain respiratory tract and wound infection agents at the minimum inhibitory concentration level. | Yanik K, Guluzade E, Bilgin K, Karadag A, Eroglu C, Birinci A, Gunaydin M. | J Infect Dev Ctries | 10.3855/jidc.6300 | 2015 | |
| Thermostable Heptaplex PCR Assay for the Detection of Six Respiratory Bacterial Pathogens. | Nik Zuraina NMN, Goni MD, Amalina KN, Hasan H, Mohamad S, Suraiya S. | Diagnostics (Basel) | 10.3390/diagnostics11050753 | 2021 | | |
| In vitro activity of lactone ketolide nafithromycin (WCK 4873) against Streptococcus pneumoniae isolates enriched with macrolide-resistance phenotype collected from mainland China. | Zhou M, Wu L, Kang W, Li Y, Zhang G, Zhang J, Duan S, Li J, Wang T, Xu Y, Gu Y. | JAC Antimicrob Resist | 10.1093/jacamr/dlac103 | 2022 | | |
| Evaluation of in vitro activity of iclaprim in combination with other antimicrobials against pulmonary pathogens: a pilot study. | Huang DB, de Piano C, Magnet S. | Access Microbiol | 10.1099/acmi.0.000027 | 2019 | | |
| Pathogenicity | Carbapenem-Nonsusceptible Haemophilus influenzae with Penicillin-Binding Protein 3 Containing an Amino Acid Insertion. | Kitaoka K, Kimura K, Kitanaka H, Banno H, Jin W, Wachino JI, Arakawa Y. | Antimicrob Agents Chemother | 10.1128/aac.00671-18 | 2018 | |
| Metabolism | Cell vacuolation induced by Haemophilus influenzae supernatants in HEp-2 cells. | Espinoza-Mellado Mdel R, Lopez-Villegas EO, Arteaga-Garibay RI, Giono-Cerezo S. | Mem Inst Oswaldo Cruz | 10.1590/0074-0276130716 | 2013 | |
| Droplet Encoding-Pairing Enabled Multiplexed Digital Loop-Mediated Isothermal Amplification for Simultaneous Quantitative Detection of Multiple Pathogens. | Cai D, Wang Y, Zou J, Li Z, Huang E, Ouyang X, Que Z, Luo Y, Chen Z, Jiang Y, Zhang G, Wu H, Liu D. | Adv Sci (Weinh) | 10.1002/advs.202205863 | 2023 | | |
| Enzymology | Comparison of PCR-based methods for the simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in clinical samples. | de Filippis I, de Andrade CF, Caldeira N, de Azevedo AC, de Almeida AE. | Braz J Infect Dis | 10.1016/j.bjid.2016.04.005 | 2016 | |
| Prevalence of gram negative bacteria causing community acquired pneumonia among adults in Mwanza City, Tanzania. | Kishimbo P, Sogone NM, Kalokola F, Mshana SE. | Pneumonia (Nathan) | 10.1186/s41479-020-00069-0 | 2020 | | |
| Molecular detection of fluoroquinolone-resistant Neisseria meningitidis by using mismatched PCR-restriction fragment length polymorphism technique. | Ota Y, Okada R, Takahashi H, Saito R. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.911911 | 2022 | | |
| Synthesis, characterization and antibacterial activity of novel heterocycle, coumacine, and two of its derivatives. | Mustafa YF. | Saudi Pharm J | 10.1016/j.jsps.2018.03.010 | 2018 | | |
| Asymptomatic nasopharyngeal carriage of multidrug resistant bacteria among children at University of Gondar Hospital Northwest Ethiopia Revealing Hidden Health Risks. | Birhanu A, Amare A, Tigabie M, Bitew G, Cherkos T, Getaneh E, Moges F. | Sci Rep | 10.1038/s41598-024-77527-y | 2024 | | |
| Design, Synthesis, and Antibacterial Evaluation of Oxazolidinones with Fused Heterocyclic C-Ring Substructure. | Deshmukh MS, Jain N. | ACS Med Chem Lett | 10.1021/acsmedchemlett.7b00263 | 2017 | | |
| Affordable blood culture systems from China: in vitro evaluation for use in resource-limited settings. | Hardy L, Vermoesen T, Genbrugge E, Natale A, Franquesa C, Gleeson B, Ferreyra C, Dailey P, Jacobs J. | EBioMedicine | 10.1016/j.ebiom.2024.105004 | 2024 | | |
| Pathogenicity | Long-term exposure to low-dose Haemophilus influenzae during allergic airway disease drives a steroid-resistant neutrophilic inflammation and promotes airway remodeling. | Yang X, Wang Y, Zhao S, Wang R, Wang C. | Oncotarget | 10.18632/oncotarget.24653 | 2018 | |
| Pathogenicity | Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics. | Ross JE, Sader HS, Ivezic-Schoenfeld Z, Paukner S, Jones RN. | J Clin Microbiol | 10.1128/jcm.01294-12 | 2012 | |
| Klebsiella pneumoniae peptide hijacks a Streptococcus pneumoniae permease to subvert pneumococcal growth and colonization. | Lux J, Portmann H, Sanchez Garcia L, Erhardt M, Holivololona L, Laloli L, Licheri MF, Gallay C, Hoepner R, Croucher NJ, Straume D, Veening JW, Dijkman R, Heller M, Grandgirard D, Leib SL, Hathaway LJ. | Commun Biol | 10.1038/s42003-024-06113-9 | 2024 | | |
| Pathogenicity | In vitro susceptibility testing of eravacycline is unaffected by medium age and nonstandard assay parameters. | Grossman TH, Pillar CM, Sahm DF, Sutcliffe JA. | Antimicrob Agents Chemother | 10.1128/aac.04727-14 | 2015 | |
| Metabolism | The Role of Regulatory T Cell in Nontypeable Haemophilus influenzae-Induced Acute Exacerbation of Chronic Obstructive Pulmonary Disease. | Guan X, Lu Y, Wang G, Gibson P, Chen F, Fang K, Wang Z, Pang Z, Guo Y, Lu J, Yuan Y, Ran N, Wang F. | Mediators Inflamm | 10.1155/2018/8387150 | 2018 | |
| Pathogenicity | Determination of Disk Diffusion and MIC Quality Control Guidelines for High-Dose Cefepime-Tazobactam (WCK 4282), a Novel Antibacterial Combination Consisting of a beta-Lactamase Inhibitor and a Fourth-Generation Cephalosporin. | Riedel S, Huband MD, Sader HS, Flamm RK, Jones RN. | J Clin Microbiol | 10.1128/jcm.00788-17 | 2017 | |
| Analysis of Microbiota and Mycobiota in Fungal Ball Rhinosinusitis: Specific Interaction between Aspergillus fumigatus and Haemophilus influenza? | Delliere S, Dannaoui E, Fieux M, Bonfils P, Gricourt G, Demontant V, Podglajen I, Woerther PL, Angebault C, Botterel F. | J Fungi (Basel) | 10.3390/jof7070550 | 2021 | | |
| Phylogeny | Reverse transcription recombinase polymerase amplification with lateral flow dipsticks for detection of influenza A virus and subtyping of H1 and H3. | Sun N, Wang W, Wang J, Yao X, Chen F, Li X, Yinglei Y, Chen B. | Mol Cell Probes | 10.1016/j.mcp.2018.10.004 | 2018 | |
| New Bicyclic Azalide Macrolides Obtained by Tandem Palladium Catalyzed Allylic Alkylation/Conjugated Addition Reaction. | Alihodzic S, Cipcic Paljetak H, Cikos A, Elenkov IJ. | Molecules | 10.3390/molecules27020432 | 2022 | | |
| Evaluation of Haemophilus influenzae type b carrier status among children 10 years after the introduction of Hib vaccine in Brazil. | Zanella RC, Brandileone MC, Andrade AL, Ogassavara CT, Fiorio CE, Brandao AP, Almeida SC, Lemos AP, Gorla MC, Carvalhanas TR, Sato H, Liphaus B, Nerger ML, Conde M, Ribeiro AF. | Mem Inst Oswaldo Cruz | 10.1590/0074-02760150140 | 2015 | | |
| Performance of the FilmArray Blood culture identification panel in positive blood culture bottles and cerebrospinal fluid for the diagnosis of sepsis and meningitis. | Leitner E, Hoenigl M, Wagner B, Krause R, Feierl G, Grisold AJ. | GMS Infect Dis | 10.3205/id000024 | 2016 | | |
| Enzymology | Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay. | Yan C, Cui J, Huang L, Du B, Chen L, Xue G, Li S, Zhang W, Zhao L, Sun Y, Yao H, Li N, Zhao H, Feng Y, Liu S, Zhang Q, Liu D, Yuan J. | Clin Microbiol Infect | 10.1016/j.cmi.2020.04.001 | 2020 | |
| Pathogenicity | Reduced levofloxacin susceptibility in clinical respiratory isolates of Haemophilus influenzae is not yet associated with mutations in the DNA gyrase and topoisomerase II genes in Korea. | Kim IS, Lee NY, Kim S, Ki CS, Kim SH. | Yonsei Med J | 10.3349/ymj.2011.52.1.188 | 2011 | |
| Pathogenicity | Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011. | Pfaller MA, Huband MD, Rhomberg PR, Flamm RK. | Antimicrob Agents Chemother | 10.1128/aac.00018-17 | 2017 | |
| In Vitro Activity of MRX-8 and Comparators Against Clinical Isolated Gram-Negative Bacilli in China. | Wu S, Yin D, Zhi P, Guo Y, Yang Y, Zhu D, Hu F. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.829592 | 2022 | | |
| Enzymology | In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China. | Zhao C, Wang X, Zhang Y, Wang R, Wang Q, Li H, Wang H. | BMC Infect Dis | 10.1186/s12879-019-4093-1 | 2019 | |
| Antimicrobial Activity of Omadacycline Tested against Clinical Bacterial Isolates from Hospitals in Mainland China, Hong Kong, and Taiwan: Results from the SENTRY Antimicrobial Surveillance Program (2013 to 2016). | Carvalhaes CG, Huband MD, Reinhart HH, Flamm RK, Sader HS. | Antimicrob Agents Chemother | 10.1128/aac.02262-18 | 2019 | | |
| Enzymology | Identification and Characterization of "Haemophilus quentini" Strains Causing Invasive Disease in Ontario, Canada (2016 to 2018). | Kus JV, Shuel M, Soares D, Hoang W, Law D, Tsang RSW. | J Clin Microbiol | 10.1128/jcm.01254-19 | 2019 | |
| Bicarbonate Inhibits Bacterial Growth and Biofilm Formation of Prevalent Cystic Fibrosis Pathogens. | Dobay O, Laub K, Stercz B, Keri A, Balazs B, Tothpal A, Kardos S, Jaikumpun P, Ruksakiet K, Quinton PM, Zsembery A. | Front Microbiol | 10.3389/fmicb.2018.02245 | 2018 | | |
| In Vitro and In Vivo Properties of CUO246, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor. | Blais J, Dean CR, Lapointe G, Leeds JA, Ma S, Morris L, Moser HE, Osborne CS, Prosen KR, Richie D, Skepper C, Thompson K, Vo J, Yue Q, Rivkin A. | Antimicrob Agents Chemother | 10.1128/aac.00921-22 | 2022 | | |
| Pathogenicity | Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents. | Petrina MAB, Cosentino LA, Wiesenfeld HC, Darville T, Hillier SL. | Anaerobe | 10.1016/j.anaerobe.2019.02.005 | 2019 | |
| Antibacterial Activity of Thymus vulgaris L. Essential Oil Vapours and Their GC/MS Analysis Using Solid-Phase Microextraction and Syringe Headspace Sampling Techniques. | Antih J, Houdkova M, Urbanova K, Kokoska L. | Molecules | 10.3390/molecules26216553 | 2021 | | |
| Pathogenicity | Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae in Canada, 2007 to 2014. | Tsang RSW, Shuel M, Whyte K, Hoang L, Tyrrell G, Horsman G, Wylie J, Jamieson F, Lefebvre B, Haldane D, Gad RR, German GJ, Needle R. | J Antimicrob Chemother | 10.1093/jac/dkw565 | 2017 | |
| Time to switch from CLSI to EUCAST? A Southeast Asian perspective. | Cusack TP, Ashley EA, Ling CL, Roberts T, Turner P, Wangrangsimakul T, Dance DAB. | Clin Microbiol Infect | 10.1016/j.cmi.2019.03.016 | 2019 | | |
| Pathogenicity | A Naturally Occurring Single Nucleotide Polymorphism in a Multicopy Plasmid Produces a Reversible Increase in Antibiotic Resistance. | Santos-Lopez A, Bernabe-Balas C, Ares-Arroyo M, Ortega-Huedo R, Hoefer A, San Millan A, Gonzalez-Zorn B. | Antimicrob Agents Chemother | 10.1128/aac.01735-16 | 2017 | |
| Pathogenicity | Exposure to low-dose arsenic in early life alters innate immune function in children. | Parvez F, Akhtar E, Khan L, Haq MA, Islam T, Ahmed D, Eunus HM, Hasan AR, Ahsan H, Graziano JH, Raqib R. | J Immunotoxicol | 10.1080/1547691x.2019.1657993 | 2019 | |
| Pathogenicity | Desertomycin G, a New Antibiotic with Activity against Mycobacterium tuberculosis and Human Breast Tumor Cell Lines Produced by Streptomyces althioticus MSM3, Isolated from the Cantabrian Sea Intertidal Macroalgae Ulva sp. | Brana AF, Sarmiento-Vizcaino A, Perez-Victoria I, Martin J, Otero L, Palacios-Gutierrez JJ, Fernandez J, Mohamedi Y, Fontanil T, Salmon M, Cal S, Reyes F, Garcia LA, Blanco G. | Mar Drugs | 10.3390/md17020114 | 2019 | |
| Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial. | McCurdy S, Keedy K, Lawrence L, Nenninger A, Sheets A, Quintas M, Cammarata S. | Antimicrob Agents Chemother | 10.1128/aac.01949-19 | 2020 | | |
| Enzymology | Characterization of nasopharyngeal isolates of type b Haemophilus influenzae from Delhi. | Saikia KK, Das BK, Bewal RK, Kapil A, Arora NK, Sood S. | Indian J Med Res | 2012 | | |
| Pathogenicity | Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15. | Zafar A, Hasan R, Nizamuddin S, Mahmood N, Mukhtar S, Ali F, Morrissey I, Barker K, Torumkuney D. | J Antimicrob Chemother | 10.1093/jac/dkw076 | 2016 | |
| Innate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae. | Augustyniak D, Jankowski A, Mackiewicz P, Skowyra A, Gutowicz J, Drulis-Kawa Z. | BMC Immunol | 10.1186/1471-2172-13-24 | 2012 | | |
| Pathogenicity | Effects of various media on the activity of NXL103 (formerly XRP 2868), a new oral streptogramin, against Haemophilus influenzae. | Pankuch GA, Hoellman D, Bryskier A, Lowther J, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.00587-06 | 2006 | |
| Phylogeny | Superior sensitivity and decreased time to detection with the Bactec Peds Plus/F system compared to the BacT/Alert Pediatric FAN blood culture system. | Sullivan KV, Turner NN, Lancaster DP, Shah AR, Chandler LJ, Friedman DF, Blecker-Shelly DL. | J Clin Microbiol | 10.1128/jcm.02205-13 | 2013 | |
| Clinical Validation of a SARS-CoV-2 Real-Time Reverse Transcription PCR Assay Targeting the Nucleocapsid Gene. | SoRelle JA, Frame I, Falcon A, Jacob J, Wagenfuehr J, Mitui M, Park JY, Filkins L. | J Appl Lab Med | 10.1093/jalm/jfaa089 | 2020 | | |
| Phylogeny | Multilocus sequence typing and ftsI sequencing: a powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae. | Skaare D, Anthonisen IL, Caugant DA, Jenkins A, Steinbakk M, Strand L, Sundsfjord A, Tveten Y, Kristiansen BE. | BMC Microbiol | 10.1186/1471-2180-14-131 | 2014 | |
| Pathogenicity | Budesonide, fluticasone propionate, and azithromycin do not modulate the membrane vesicle release by THP-1 macrophages and respiratory pathogens during macrophage infection. | Volgers C, Grauls GE, Hellebrand PHM, Savelkoul PHM, Stassen FRM. | Inflammopharmacology | 10.1007/s10787-017-0359-7 | 2017 | |
| Investigations of a Possible Chemical Effect of Salvadora persica Chewing Sticks. | Albabtain R, Azeem M, Wondimu Z, Lindberg T, Borg-Karlson AK, Gustafsson A. | Evid Based Complement Alternat Med | 10.1155/2017/2576548 | 2017 | | |
| Pathogenicity | Nasopharyngeal carriage and antimicrobial susceptibility of Haemophilus influenzae among children younger than 5 years of age in Beijing, China. | Zhu H, Wang A, Tong J, Yuan L, Gao W, Shi W, Yu S, Yao K, Yang Y. | BMC Microbiol | 10.1186/s12866-015-0350-7 | 2015 | |
| Pathogenicity | MIC quality control guidelines and disk diffusion test optimization for CEM-101, a novel fluoroketolide. | Jones RN, Ross JE, Rhomberg PR, Quality Control Working Group. | J Clin Microbiol | 10.1128/jcm.01992-09 | 2010 | |
| Enzymology | Improvement rate of acute otitis media caused by Haemophilus influenzae at 1 week is significantly associated with time to recovery. | Yano H, Yamazaki Y, Qin L, Okitsu N, Yahara K, Irimada M, Hirakata Y, Kaku M, Kobayashi T, Watanabe H. | J Clin Microbiol | 10.1128/jcm.01108-13 | 2013 | |
| Pathogenicity | In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus. | Barman TK, Kumar M, Mathur T, Namba E, Singh D, Chaira T, Kurosaka Y, Yamada M, Upadhyay DJ, Masuda N. | Antimicrob Agents Chemother | 10.1128/aac.02556-17 | 2018 | |
| Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates. | Puig C, Tirado-Velez JM, Calatayud L, Tubau F, Garmendia J, Ardanuy C, Marti S, de la Campa AG, Linares J. | Antimicrob Agents Chemother | 10.1128/aac.04005-14 | 2015 | | |
| Direct Detection of Streptococcus suis from Cerebrospinal Fluid, Positive Hemoculture, and Simultaneous Differentiation of Serotypes 1, 1/2, 2, and 14 within Single Reaction. | Thu ISL, Tragoolpua K, Intorasoot S, Anukool U, Khamnoi P, Kerdsin A, Tharinjaroen CS. | Pathogens | 10.3390/pathogens10080996 | 2021 | | |
| Pathogenicity | In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program. | Flamm RK, Rhomberg PR, Sader HS. | Antimicrob Agents Chemother | 10.1128/aac.01230-17 | 2017 | |
| Admission Outcome and Antimicrobial Resistance Pattern of Bacterial Isolates among Neonates with Suspected Sepsis in Neonatal Intensive Care Unit at Dessie Comprehensive Specialized Hospital, Dessie, Northeastern Ethiopia. | Fenta GM, Woldemariam HK, Metaferia Y, Seid A, Gebretsadik D. | Interdiscip Perspect Infect Dis | 10.1155/2022/1318295 | 2022 | | |
| Pathogenicity | Haemophilus influenzae with Non-Beta-Lactamase-Mediated Beta-Lactam Resistance: Easy To Find but Hard To Categorize. | Skaare D, Lia A, Hannisdal A, Tveten Y, Matuschek E, Kahlmeter G, Kristiansen BE. | J Clin Microbiol | 10.1128/jcm.01630-15 | 2015 | |
| Comparison of the Performance of Three Blood Culture Systems in a Chinese Tertiary-Care Hospital. | Li G, Sun J, Pan S, Li W, Zhang S, Wang Y, Sun X, Xu H, Ming L. | Front Cell Infect Microbiol | 10.3389/fcimb.2019.00285 | 2019 | | |
| Pathogenicity | Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin. | Li X, Mariano N, Rahal JJ, Urban CM, Drlica K. | Antimicrob Agents Chemother | 10.1128/aac.48.11.4460-4462.2004 | 2004 | |
| Enhanced Anti-Bacterial Activity Of Biogenic Silver Nanoparticles Synthesized From Terminalia mantaly Extracts. | Majoumouo MS, Sibuyi NRS, Tincho MB, Mbekou M, Boyom FF, Meyer M. | Int J Nanomedicine | 10.2147/ijn.s223447 | 2019 | | |
| Pathogenicity | Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey. | Torumkuney D, Gur D, Soyletir G, Gurler N, Aktas Z, Sener B, Tunger A, Bayramoglu G, Koksal I, Yalcin AN, Tanriver Y, Morrissey I, Barker K. | J Antimicrob Chemother | 10.1093/jac/dkw067 | 2016 | |
| Pathogenicity | Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Ukraine. | Feshchenko Y, Dzyublik A, Pertseva T, Bratus E, Dzyublik Y, Gladka G, Morrissey I, Torumkuney D. | J Antimicrob Chemother | 10.1093/jac/dkw068 | 2016 | |
| Enzymology | Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections. | Gadsby NJ, McHugh MP, Russell CD, Mark H, Conway Morris A, Laurenson IF, Hill AT, Templeton KE. | Clin Microbiol Infect | 10.1016/j.cmi.2015.05.004 | 2015 | |
| Enzymology | Microbiological characterization of Streptococcus pneumoniae and non-typeable Haemophilus influenzae isolates as primary causes of acute otitis media in Bulgarian children before the introduction of conjugate vaccines. | Setchanova LP, Kostyanev T, Alexandrova AB, Mitov IG, Nashev D, Kantardjiev T. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-12-6 | 2013 | |
| Pathogenicity | Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong. | Ho PL, Chow KH, Mak GC, Tsang KW, Lau YL, Ho AY, Lai EL, Chiu SS. | Emerg Infect Dis | 10.3201/eid1011.040055 | 2004 | |
| Phylogeny | Antibiotic susceptibility of invasive Haemophilus influenzae strains in Canada. | Sill ML, Tsang RS. | Antimicrob Agents Chemother | 10.1128/aac.01580-07 | 2008 | |
| Immunomodulatory role for membrane vesicles released by THP-1 macrophages and respiratory pathogens during macrophage infection. | Volgers C, Benedikter BJ, Grauls GE, Savelkoul PHM, Stassen FRM. | BMC Microbiol | 10.1186/s12866-017-1122-3 | 2017 | | |
| Adhesion of respiratory-infection-associated microorganisms on degradable thermoplastic composites. | Tirri T, Soderling E, Malin M, Peltola M, Seppala JV, Narhi TO. | Int J Biomater | 10.1155/2009/765813 | 2009 | | |
| Pathogenicity | Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008). | Tomic V, Dowzicky MJ. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-014-0052-2 | 2014 | |
| Pathogenicity | Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 and 2013-14 in China. | Hu F, Zhu D, Wang F, Morrissey I, Wang J, Torumkuney D. | J Antimicrob Chemother | 10.1093/jac/dkw065 | 2016 | |
| Results from the Solithromycin International Surveillance Program (2014). | Farrell DJ, Flamm RK, Sader HS, Jones RN. | Antimicrob Agents Chemother | 10.1128/aac.00185-16 | 2016 | | |
| Pathogenicity | Analysis of MIC and Disk Diffusion Testing Variables for Gepotidacin and Comparator Agents against Select Bacterial Pathogens. | Koeth LM, DiFranco-Fisher JM, Scangarella-Oman NE, Miller LA. | J Clin Microbiol | 10.1128/jcm.02366-16 | 2017 | |
| Pathogenicity | Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016. | Pfaller MA, Flamm RK, Mendes RE, Streit JM, Smart JI, Hamed KA, Duncan LR, Sader HS. | Antimicrob Agents Chemother | 10.1128/aac.01566-18 | 2019 | |
| Enzymology | Evaluation of five real-time PCR assays for detection of Mycoplasma pneumoniae. | Dumke R, Jacobs E. | J Clin Microbiol | 10.1128/jcm.02048-14 | 2014 | |
| Metabolism | Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif. | Hallstrom T, Singh B, Kraiczy P, Hammerschmidt S, Skerka C, Zipfel PF, Riesbeck K. | PLoS One | 10.1371/journal.pone.0147709 | 2016 | |
| Pathogenicity | Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. | Garcia-Cobos S, Campos J, Lazaro E, Roman F, Cercenado E, Garcia-Rey C, Perez-Vazquez M, Oteo J, de Abajo F. | Antimicrob Agents Chemother | 10.1128/aac.00354-07 | 2007 | |
| Enzymology | Accurate, rapid and low-cost diagnosis of Mycoplasma pneumoniae via fast narrow-thermal-cycling denaturation bubble-mediated strand exchange amplification. | Yang C, Li Y, Deng J, Li M, Ma C, Shi C. | Anal Bioanal Chem | 10.1007/s00216-020-02977-y | 2020 | |
| Antibacterial Profile of a Microbicidal Agent Targeting Tyrosine Phosphatases and Redox Thiols, Novel Drug Targets. | White K, Nicoletti G, Cornell H. | Antibiotics (Basel) | 10.3390/antibiotics10111310 | 2021 | | |
| Frequency of Pathogenic Paediatric Bacterial Meningitis in Mozambique: The Critical Role of Multiplex Real-Time Polymerase Chain Reaction to Estimate the Burden of Disease. | Nhantumbo AA, Cantarelli VV, Caireao J, Munguambe AM, Come CE, Pinto Gdo C, Zimba TF, Mandomando I, Sema CB, Dias C, Moraes MO, Gudo ES. | PLoS One | 10.1371/journal.pone.0138249 | 2015 | | |
| Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens. | Landini G, Di Maggio T, Sergio F, Docquier JD, Rossolini GM, Pallecchi L. | Antimicrob Agents Chemother | 10.1128/aac.01334-16 | 2016 | | |
| Multicenter Performance Evaluation of the Simplexa Bordetella Direct Kit in Nasopharyngeal Swab Specimens. | Chow SK, Arbefeville S, Boyanton BL, Dault EM, Dunn J, Ferrieri P, Greene W, Pence MA, Otiso J, Richter S, Schutzbank TE. | J Clin Microbiol | 10.1128/jcm.01041-20 | 2020 | | |
| Pathogenicity | Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion. | Tarran R, Sabater JR, Clarke TC, Tan CD, Davies CM, Liu J, Yeung A, Garland AL, Stutts MJ, Abraham WM, Phillips G, Baker WR, Wright CD, Wilbert S. | Am J Physiol Lung Cell Mol Physiol | 10.1152/ajplung.00292.2012 | 2013 | |
| Increased Antimicrobial Resistance among Sputum Pathogens from Patients with Hyperglycemia. | Yi H, Huang J, Guo L, Zhang Q, Qu J, Zhou M. | Infect Drug Resist | 10.2147/idr.s243732 | 2020 | | |
| Pathogenicity | Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections. | Bruhn DF, Waidyarachchi SL, Madhura DB, Shcherbakov D, Zheng Z, Liu J, Abdelrahman YM, Singh AP, Duscha S, Rathi C, Lee RB, Belland RJ, Meibohm B, Rosch JW, Bottger EC, Lee RE. | Sci Transl Med | 10.1126/scitranslmed.3010572 | 2015 | |
| Genetics | Multilaboratory assessment of metagenomic next-generation sequencing for unbiased microbe detection. | Han D, Diao Z, Lai H, Han Y, Xie J, Zhang R, Li J. | J Adv Res | 10.1016/j.jare.2021.09.011 | 2022 | |
| Enzymology | Bacterial etiology of ocular and periocular infections, antimicrobial susceptibility profile and associated factors among patients attending eye unit of Shashemene comprehensive specialized hospital, Shashemene, Ethiopia. | Mohammed AA, Ali MM, Zenebe MH. | BMC Ophthalmol | 10.1186/s12886-020-01398-w | 2020 | |
| Phylogeny | Non-capsulated and capsulated Haemophilus influenzae in children with acute otitis media in Venezuela: a prospective epidemiological study. | Naranjo L, Suarez JA, DeAntonio R, Sanchez F, Calvo A, Spadola E, Rodriguez N, Andrade O, Bertuglia F, Marquez N, Castrejon MM, Ortega-Barria E, Colindres RE. | BMC Infect Dis | 10.1186/1471-2334-12-40 | 2012 | |
| Activity of Ceftaroline against Aerobic Gram-Positive and Gram-Negative Pathogens: Effect of Test Method Variability. | Citron DM, Warren YA, Tyrrell KL, Goldstein EJ. | ISRN Microbiol | 10.5402/2011/787290 | 2011 | | |
| Phylogeny | Exacerbation induces a microbiota shift in sputa of COPD patients. | Jubinville E, Veillette M, Milot J, Maltais F, Comeau AM, Levesque RC, Duchaine C. | PLoS One | 10.1371/journal.pone.0194355 | 2018 | |
| Contribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones. | Haas W, Sanfilippo CM, Hesje CK, Morris TW. | Clin Ophthalmol | 10.2147/opth.s44085 | 2013 | | |
| Pathogenicity | Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam. | Van PH, Binh PT, Minh NH, Morrissey I, Torumkuney D. | J Antimicrob Chemother | 10.1093/jac/dkw069 | 2016 | |
| Pathogenicity | Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence. | Bhagwat SS, Nandanwar M, Kansagara A, Patel A, Takalkar S, Chavan R, Periasamy H, Yeole R, Deshpande PK, Bhavsar S, Bhatia A, Ahdal J, Jain R, Patel M. | Drug Des Devel Ther | 10.2147/dddt.s229882 | 2019 | |
| Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used. | Anderegg TR, Jones RN, Sader HS, Quality Control Working Group. | J Clin Microbiol | 10.1128/jcm.42.7.3356-3358.2004 | 2004 | | |
| Small-plasmid-mediated antibiotic resistance is enhanced by increases in plasmid copy number and bacterial fitness. | San Millan A, Santos-Lopez A, Ortega-Huedo R, Bernabe-Balas C, Kennedy SP, Gonzalez-Zorn B. | Antimicrob Agents Chemother | 10.1128/aac.00235-15 | 2015 | | |
| Pathogenicity | Molecular epidemiology of ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae. | Gazagne L, Delmas C, Bingen E, Dabernat H. | J Clin Microbiol | 10.1128/jcm.36.12.3629-3635.1998 | 1998 | |
| Enzymology | Development and comparison of a real-time PCR assay for detection of Dichelobacter nodosus with culturing and conventional PCR: harmonisation between three laboratories. | Frosth S, Slettemeas JS, Jorgensen HJ, Angen O, Aspan A. | Acta Vet Scand | 10.1186/1751-0147-54-6 | 2012 | |
| Pathogenicity | Exposure to common respiratory bacteria alters the airway epithelial response to subsequent viral infection. | Bellinghausen C, Gulraiz F, Heinzmann AC, Dentener MA, Savelkoul PH, Wouters EF, Rohde GG, Stassen FR. | Respir Res | 10.1186/s12931-016-0382-z | 2016 | |
| Pathogenicity | Progressive increase in antimicrobial resistance among invasive isolates of Haemophilus influenzae obtained from children admitted to a hospital in Kilifi, Kenya, from 1994 to 2002. | Scott JA, Mwarumba S, Ngetsa C, Njenga S, Lowe BS, Slack MP, Berkley JA, Mwangi I, Maitland K, English M, Marsh K. | Antimicrob Agents Chemother | 10.1128/aac.49.7.3021-3024.2005 | 2005 | |
| Enzymology | Simultaneous Extraction of Viral and Bacterial Nucleic Acids for Molecular Diagnostic Applications. | Kajiura LN, Stewart SD, Dresios J, Uyehara CF. | J Biomol Tech | 10.7171/jbt.15-2604-002 | 2015 | |
| Pathogenicity | Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method. | Garcia-Cobos S, Campos J, Roman F, Carrera C, Perez-Vazquez M, Aracil B, Oteo J. | Antimicrob Agents Chemother | 10.1128/aac.00214-08 | 2008 | |
| Enzymology | Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination. | San Millan A, Garcia-Cobos S, Escudero JA, Hidalgo L, Gutierrez B, Carrilero L, Campos J, Gonzalez-Zorn B. | Antimicrob Agents Chemother | 10.1128/aac.01489-09 | 2010 | |
| Pathogenicity | In vitro antimicrobial activity of a new cephalosporin, ceftaroline, and determination of quality control ranges for MIC testing. | Brown SD, Traczewski MM. | Antimicrob Agents Chemother | 10.1128/aac.01021-08 | 2009 | |
| Pathogenicity | Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. | Heilmann KP, Rice CL, Miller AL, Miller NJ, Beekmann SE, Pfaller MA, Richter SS, Doern GV. | Antimicrob Agents Chemother | 10.1128/aac.49.6.2561-2564.2005 | 2005 | |
| Metabolism | Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp. | Hassan HM, Degen D, Jang KH, Ebright RH, Fenical W. | J Antibiot (Tokyo) | 10.1038/ja.2014.122 | 2015 | |
| Direct molecular detection of amoxicillin-susceptible E. coli in urine samples from children with suspected urinary tract infection: A potential tool to improve antibiotic stewardship and patient care. | Slinger R, Dewpura T, Verma N, Bowes J, Barrowman N, Toye B. | J Assoc Med Microbiol Infect Dis Can | 10.3138/jammi.2019-0001 | 2019 | | |
| A broad range assay for rapid detection and etiologic characterization of bacterial meningitis: performance testing in samples from sub-Sahara. | Won H, Yang S, Gaydos C, Hardick J, Ramachandran P, Hsieh YH, Kecojevic A, Njanpop-Lafourcade BM, Mueller JE, Tameklo TA, Badziklou K, Gessner BD, Rothman RE. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2012.05.015 | 2012 | | |
| Pathogenicity | Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance. | Bae S, Lee J, Lee J, Kim E, Lee S, Yu J, Kang Y. | Antimicrob Agents Chemother | 10.1128/aac.00966-09 | 2010 | |
| Enzymology | A novel, multiplex, real-time PCR-based approach for the detection of the commonly occurring pathogenic fungi and bacteria. | Horvath A, Peto Z, Urban E, Vagvolgyi C, Somogyvari F. | BMC Microbiol | 10.1186/1471-2180-13-300 | 2013 | |
| Pathogenicity | Global assessment of antimicrobial susceptibility among Gram-negative organisms collected from pediatric patients between 2004 and 2012: results from the Tigecycline Evaluation and Surveillance Trial. | Kehl SC, Dowzicky MJ. | J Clin Microbiol | 10.1128/jcm.03184-14 | 2015 | |
| Streptococcus pneumoniae serotype prevalence and antibiotic resistance among young children with invasive pneumococcal disease: experience from a tertiary care center in South India. | Nagaraj S, Kalal BS, Manoharan A, Shet A. | Germs | 10.18683/germs.2017.1112 | 2017 | | |
| Pathogenicity | In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. | Brueggemann AB, Doern GV, Huynh HK, Wingert EM, Rhomberg PR. | Antimicrob Agents Chemother | 10.1128/aac.44.2.447-449.2000 | 2000 | |
| Metabolism | Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media. | Barry AL, Fuchs PC, Brown SD. | Antimicrob Agents Chemother | 10.1128/aac.45.5.1585-1588.2001 | 2001 | |
| Phylogeny | Polymorphism in ftsI gene and {beta}-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of beta-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid. | Barbosa AR, Giufre M, Cerquetti M, Bajanca-Lavado MP. | J Antimicrob Chemother | 10.1093/jac/dkq533 | 2011 | |
| Pathogenicity | Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010. | Paukner S, Sader HS, Ivezic-Schoenfeld Z, Jones RN. | Antimicrob Agents Chemother | 10.1128/aac.00358-13 | 2013 | |
| Pathogenicity | Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae. | Haas W, Pillar CM, Hesje CK, Sanfilippo CM, Morris TW. | J Antimicrob Chemother | 10.1093/jac/dkq127 | 2010 | |
| Detection of respiratory viruses and bacteria in children using a twenty-two target reverse-transcription real-time PCR (RT-qPCR) panel. | Ellis C, Misir A, Hui C, Jabbour M, Barrowman N, Langill J, Bowes J, Slinger R. | World J Pediatr | 10.1007/s12519-015-0069-4 | 2016 | | |
| A novel real-time PCR assay for specific detection of Brucella melitensis. | Kaden R, Ferrari S, Alm E, Wahab T. | BMC Infect Dis | 10.1186/s12879-017-2327-7 | 2017 | | |
| Pathogenicity | Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. | Kaczmarek FS, Gootz TD, Dib-Hajj F, Shang W, Hallowell S, Cronan M. | Antimicrob Agents Chemother | 10.1128/aac.48.5.1630-1639.2004 | 2004 | |
| Pathogenicity | Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010. | Flamm RK, Sader HS, Jones RN. | Braz J Infect Dis | 10.1016/j.bjid.2013.02.008 | 2013 | |
| Pathogenicity | Results from the Survey of Antibiotic Resistance (SOAR) 2011-14 in the Democratic Republic of Congo, Ivory Coast, Republic of Senegal and Kenya. | Kacou-Ndouba A, Revathi G, Mwathi P, Seck A, Diop A, Kabedi-Bajani MJ, Mwiti W, Anguibi-Pokou MJ, Morrissey I, Torumkuney D. | J Antimicrob Chemother | 10.1093/jac/dkw070 | 2016 | |
| Pathogenicity | Activities of HMR 3787 and RU 64399 compared with those of four other agents against Haemophilus influenzae and Haemophilus parainfluenzae. | Bozdogan B, Clark C, Bryskier A, Jacobs MR, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.47.1.405-407.2003 | 2003 | |
| Enzymology | Real-time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding. | Ramirez-Lazaro MJ, Ramirez-Lazaro MJ, Lario S, Casalots A, Sanfeliu E, Boix L, Garcia-Iglesias P, Sanchez-Delgado J, Montserrat A, Bella-Cueto MR, Gallach M, Sanfeliu I, Segura F, Calvet X, Calvet X. | PLoS One | 10.1371/journal.pone.0020009 | 2011 | |
| Pathogenicity | Antimicrobial resistance in Haemophilus influenzae isolated during population-based surveillance for meningitis in Salvador, Brazil. | Reis JN, Lima JB, Ribeiro GS, Corderio SM, Salgado K, Reis MG, Ko AI. | Antimicrob Agents Chemother | 10.1128/aac.46.11.3641-3643.2002 | 2002 | |
| Characterization of antimicrobial resistance genes in Haemophilus parasuis isolated from pigs in China. | Zhao Y, Guo L, Li J, Huang X, Fang B. | PeerJ | 10.7717/peerj.4613 | 2018 | | |
| Pathogenicity | Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pH. | Nilius AM, Beyer JM, Flamm RK, Tanaka SK. | J Clin Microbiol | 10.1128/jcm.35.6.1311-1315.1997 | 1997 | |
| Pathogenicity | Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactams. | Barry AL, Jorgensen JH, Hardy DJ, Allen SD, Baker CN. | J Clin Microbiol | 10.1128/jcm.30.8.2033-2037.1992 | 1992 | |
| Pathogenicity | Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain. | Jorgensen JH, Barry AL, Doern GV, Ferraro MJ, Murray PR. | J Clin Microbiol | 10.1128/jcm.30.8.2029-2032.1992 | 1992 | |
| Pathogenicity | Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions. | Hirakata Y, Ohmori K, Mikuriya M, Saika T, Matsuzaki K, Hasegawa M, Hatta M, Yamamoto N, Kunishima H, Yano H, Kitagawa M, Arai K, Kawakami K, Kobayashi I, Jones RN, Kohno S, Yamaguchi K, Kaku M. | Antimicrob Agents Chemother | 10.1128/aac.00192-09 | 2009 | |
| Pathogenicity | Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in the Gulf States. | Jamsheer A, Rafay AM, Daoud Z, Morrissey I, Torumkuney D. | J Antimicrob Chemother | 10.1093/jac/dkw064 | 2016 | |
| Pathogenicity | Grindelia squarrosa Extract and Grindelic Acid Modulate Pro-inflammatory Functions of Respiratory Epithelium and Human Macrophages. | Gierlikowska B, Filipek A, Gierlikowski W, Kania D, Stefanska J, Demkow U, Kiss AK. | Front Pharmacol | 10.3389/fphar.2020.534111 | 2020 | |
| Enzymology | Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations. | Perez-Vazquez M, Roman F, Aracil B, Canton R, Campos J. | J Clin Microbiol | 10.1128/jcm.42.3.1185-1191.2004 | 2004 | |
| Pathogenicity | In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria. | Huband MD, Bradford PA, Otterson LG, Basarab GS, Kutschke AC, Giacobbe RA, Patey SA, Alm RA, Johnstone MR, Potter ME, Miller PF, Mueller JP. | Antimicrob Agents Chemother | 10.1128/aac.04124-14 | 2015 | |
| Pathogenicity | Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011). | Flamm RK, Sader HS, Jones RN. | Braz J Infect Dis | 10.1016/j.bjid.2013.11.005 | 2014 | |
| Pathogenicity | In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria. | Ito A, Sato T, Ota M, Takemura M, Nishikawa T, Toba S, Kohira N, Miyagawa S, Ishibashi N, Matsumoto S, Nakamura R, Tsuji M, Yamano Y. | Antimicrob Agents Chemother | 10.1128/aac.01454-17 | 2018 | |
| Quality control limits for dilution and disk diffusion susceptibility tests of trovafloxacin against eight quality control strains. | Fuchs PC, Barry AL, Brown SD. | J Clin Microbiol | 10.1128/jcm.36.2.585-586.1998 | 1998 | | |
| Pathogenicity | In vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations. | Doern GV. | J Clin Microbiol | 10.1128/jcm.30.12.3035-3038.1992 | 1992 | |
| Improved selective isolation of Bordetella pertussis by use of modified cyclodextrin solid medium. | Ohtsuka M, Kikuchi K, Shundo K, Okada K, Higashide M, Sunakawa K, Hiramatsu K. | J Clin Microbiol | 10.1128/jcm.00176-09 | 2009 | | |
| Targeting Bacterial Cell Division: A Binding Site-Centered Approach to the Most Promising Inhibitors of the Essential Protein FtsZ. | Casiraghi A, Suigo L, Valoti E, Straniero V. | Antibiotics (Basel) | 10.3390/antibiotics9020069 | 2020 | | |
| Pathogenicity | Beta- lactam antibiotics stimulate biofilm formation in non-typeable haemophilus influenzae by up-regulating carbohydrate metabolism. | Wu S, Li X, Gunawardana M, Maguire K, Guerrero-Given D, Schaudinn C, Wang C, Baum MM, Webster P. | PLoS One | 10.1371/journal.pone.0099204 | 2014 | |
| Transcriptome | Rapid pathogen identification using a novel microarray-based assay with purulent meningitis in cerebrospinal fluid. | Hou Y, Zhang X, Hou X, Wu R, Wang Y, He X, Wang L, Wang Z. | Sci Rep | 10.1038/s41598-018-34051-0 | 2018 | |
| Pathogenicity | Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories. | Gesu GP, Marchetti F, Piccoli L, Cavallero A. | Antimicrob Agents Chemother | 10.1128/aac.47.2.816-819.2003 | 2003 | |
| Enzymology | Development of a new chlamydiales-specific real-time PCR and its application to respiratory clinical samples. | Lienard J, Croxatto A, Aeby S, Jaton K, Posfay-Barbe K, Gervaix A, Greub G. | J Clin Microbiol | 10.1128/jcm.00114-11 | 2011 | |
| Pathogenicity | Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. | Marco F, Garcia-de-Lomas J, Garcia-Rey C, Bouza E, Aguilar L, Fernandez-Mazarrasa C, Spanish Surveillance Group for Respiratory Pathogens. | Antimicrob Agents Chemother | 10.1128/aac.45.11.3226-3228.2001 | 2001 | |
| Development of a broad-range 23S rDNA real-time PCR assay for the detection and quantification of pathogenic bacteria in human whole blood and plasma specimens. | Gaibani P, Mariconti M, Bua G, Bonora S, Sassera D, Landini MP, Mulatto P, Novati S, Bandi C, Sambri V. | Biomed Res Int | 10.1155/2013/264651 | 2013 | | |
| Pathogenicity | Results from the Survey of Antibiotic Resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore. | Torumkuney D, Chaiwarith R, Reechaipichitkul W, Malatham K, Chareonphaibul V, Rodrigues C, Chitins DS, Dias M, Anandan S, Kanakapura S, Park YJ, Lee K, Lee H, Kim JY, Lee Y, Lee HK, Kim JH, Tan TY, Heng YX, Mukherjee P, Morrissey I. | J Antimicrob Chemother | 10.1093/jac/dkw073 | 2016 | |
| Characteristics of Haemophilus influenzae type b responsible for meningitis in Poland from 1997 to 2004. | Skoczynska A, Kadlubowski M, Empel J, Hryniewicz W. | J Clin Microbiol | 10.1128/jcm.43.11.5665-5669.2005 | 2005 | | |
| Pathogenicity | Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010. | Farrell DJ, Flamm RK, Sader HS, Jones RN. | Antimicrob Agents Chemother | 10.1128/aac.02465-14 | 2014 | |
| Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group. | Bale MJ, Jones RN. | J Clin Microbiol | 10.1128/jcm.31.9.2538-2540.1993 | 1993 | | |
| Pathogenicity | Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007). | Kresken M, Leitner E, Seifert H, Peters G, von Eiff C. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-009-0725-5 | 2009 | |
| Pathogenicity | Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. | Neuhauser MM, Prause JL, Danziger LH, Pendland SL. | Antimicrob Agents Chemother | 10.1128/aac.45.12.3613-3615.2001 | 2001 | |
| Pathogenicity | In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis. | Goldstein EJ, Citron DM, Merriam CV, Warren Y, Tyrrel KL, Fernandez H. | Antimicrob Agents Chemother | 10.1128/aac.47.6.1963-1967.2003 | 2003 | |
| Pathogenicity | CEM-101 activity against Gram-positive organisms. | Woosley LN, Castanheira M, Jones RN. | Antimicrob Agents Chemother | 10.1128/aac.01662-09 | 2010 | |
| Enzymology | Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease. | Wang H, Gu X, Weng Y, Xu T, Fu Z, Peng W, Yu W. | BMC Pulm Med | 10.1186/s12890-015-0094-z | 2015 | |
| Pathogenicity | Antibiotic resistance in Haemophilus influenzae decreased, except for beta-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in Spain from 1997 to 2007. | Garcia-Cobos S, Campos J, Cercenado E, Roman F, Lazaro E, Perez-Vazquez M, de Abajo F, Oteo J. | Antimicrob Agents Chemother | 10.1128/aac.01674-07 | 2008 | |
| In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study. | Biedenbach DJ, Badal RE, Huang MY, Motyl M, Singhal PK, Kozlov RS, Roman AD, Marcella S. | Infect Dis Ther | 10.1007/s40121-016-0112-3 | 2016 | | |
| Metabolism | Structure-based gene targeting discovery of sphaerimicin, a bacterial translocase I inhibitor. | Funabashi M, Baba S, Takatsu T, Kizuka M, Ohata Y, Tanaka M, Nonaka K, Spork AP, Ducho C, Chen WC, Van Lanen SG. | Angew Chem Int Ed Engl | 10.1002/anie.201305546 | 2013 | |
| Pathogenicity | Commercial broth microdilution panel validation and reproducibility trials for garenoxacin (BMS-284756), a novel desfluoroquinolone. | Gordon KA, Rhomberg PR, Jones RN. | J Clin Microbiol | 10.1128/jcm.41.8.3967-3969.2003 | 2003 | |
| Evaluation of Senna tora (L.) Roxb. leaves as source of bioactive molecules with antioxidant, anti-inflammatory and antibacterial potential. | Rahman MM, Al Noman MA, Khatun S, Alam R, Shetu MMH, Talukder EK, Imon RR, Biswas MY, Anis-Ul-Haque KM, Uddin MJ, Akhter S. | Heliyon | 10.1016/j.heliyon.2023.e12855 | 2023 | | |
| Pathogenicity | Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria. | Charrier C, Salisbury AM, Savage VJ, Duffy T, Moyo E, Chaffer-Malam N, Ooi N, Newman R, Cheung J, Metzger R, McGarry D, Pichowicz M, Sigerson R, Cooper IR, Nelson G, Butler HS, Craighead M, Ratcliffe AJ, Best SA, Stokes NR. | Antimicrob Agents Chemother | 10.1128/aac.02100-16 | 2017 | |
| Prevalence of Resistance to beta-Lactam Antibiotics and bla Genes Among Commensal Haemophilus parainfluenzae Isolates from Respiratory Microbiota in Poland. | Andrzejczuk S, Kosikowska U, Chwiejczak E, Stepien-Pysniak D, Malm A. | Microorganisms | 10.3390/microorganisms7100427 | 2019 | | |
| Enzymology | Rapid detection of Klebsiella pneumoniae from blood culture bottles by real-time PCR. | Kurupati P, Chow C, Kumarasinghe G, Poh CL. | J Clin Microbiol | 10.1128/jcm.42.3.1337-1340.2004 | 2004 | |
| Metabolism | Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415. | Dean CR, Narayan S, Daigle DM, Dzink-Fox JL, Puyang X, Bracken KR, Dean KE, Weidmann B, Yuan Z, Jain R, Ryder NS. | Antimicrob Agents Chemother | 10.1128/aac.49.8.3129-3135.2005 | 2005 | |
| Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. | Kim IS, Ki CS, Kim S, Oh WS, Peck KR, Song JH, Lee K, Lee NY. | Antimicrob Agents Chemother | 10.1128/aac.00960-06 | 2007 | | |
| Cultivation | Hair sheep blood, citrated or defibrinated, fulfills all requirements of blood agar for diagnostic microbiology laboratory tests. | Yeh E, Pinsky BA, Banaei N, Baron EJ. | PLoS One | 10.1371/journal.pone.0006141 | 2009 | |
| Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing. | Turnidge J, Bordash G. | Antimicrob Agents Chemother | 10.1128/aac.01457-06 | 2007 | | |
| Pathogenicity | Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322. | O'Dwyer K, Hackel M, Hightower S, Hoban D, Bouchillon S, Qin D, Aubart K, Zalacain M, Butler D. | Antimicrob Agents Chemother | 10.1128/aac.02566-12 | 2013 | |
| Pathogenicity | Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era. | Tsang RS, Mubareka S, Sill ML, Wylie J, Skinner S, Law DK. | J Clin Microbiol | 10.1128/jcm.44.4.1530-1535.2006 | 2006 | |
| Metabolism | Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. | Bogdanovich T, Bozdogan B, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.50.3.893-898.2006 | 2006 | |
| Enzymology | In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugs. | Caspers P, Bury L, Gaucher B, Heim J, Shapiro S, Siegrist S, Schmitt-Hoffmann A, Thenoz L, Urwyler H. | Antimicrob Agents Chemother | 10.1128/aac.00377-09 | 2009 | |
| Pathogenicity | Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial. | Morfin-Otero R, Noriega ER, Dowzicky MJ. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-015-0116-y | 2015 | |
| Pathogenicity | In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities. | Perez-Vazquez M, Roman F, Aracil B, Canton R, Campos J. | Antimicrob Agents Chemother | 10.1128/aac.47.11.3539-3541.2003 | 2003 | |
| Pathogenicity | In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis. | Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT. | Antimicrob Agents Chemother | 10.1128/aac.47.9.3008-3011.2003 | 2003 | |
| Pathogenicity | Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin. | Fuchs PC, Barry AL, Brown SD. | J Clin Microbiol | 10.1128/jcm.39.1.43-46.2001 | 2001 | |
| Pathogenicity | Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. | Piccolomini R, Catamo G, Di Bonaventura G. | Antimicrob Agents Chemother | 10.1128/aac.42.11.3000 | 1998 | |
| Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program. | Flamm RK, Sader HS, Farrell DJ, Jones RN. | Antimicrob Agents Chemother | 10.1128/aac.00330-12 | 2012 | | |
| Pathogenicity | Small-molecule inhibitors of gram-negative lipoprotein trafficking discovered by phenotypic screening. | McLeod SM, Fleming PR, MacCormack K, McLaughlin RE, Whiteaker JD, Narita S, Mori M, Tokuda H, Miller AA. | J Bacteriol | 10.1128/jb.02352-14 | 2015 | |
| Bacteriological Profile and Antimicrobial Susceptibility Pattern of Blood Culture Isolates among Septicemia Suspected Children in Selected Hospitals Addis Ababa, Ethiopia. | Negussie A, Mulugeta G, Bedru A, Ali I, Shimeles D, Lema T, Aseffa A. | Int J Biol Med Res | 2015 | | ||
| Pathogenicity | In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations. | De Vecchi E, Nicola L, Larosa M, Drago L. | BMC Microbiol | 10.1186/1471-2180-8-23 | 2008 | |
| Pathogenicity | Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program. | Gordon KA, Fusco J, Biedenbach DJ, Pfaller MA, Jones RN. | Antimicrob Agents Chemother | 10.1128/aac.45.12.3599-3600.2001 | 2001 | |
| Pathogenicity | First characterization of heterogeneous resistance to imipenem in invasive nontypeable Haemophilus influenzae isolates. | Cerquetti M, Giufre M, Cardines R, Mastrantonio P. | Antimicrob Agents Chemother | 10.1128/aac.00335-07 | 2007 | |
| Pathogenicity | Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines. | Heelan JS, Chesney D, Guadagno G. | J Clin Microbiol | 10.1128/jcm.30.7.1674-1677.1992 | 1992 | |
| Pathogenicity | Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 respiratory season. | Hsueh PR, Liu YC, Shyr JM, Wu TL, Yan JJ, Wu JJ, Leu HS, Chuang YC, YJ Lau, Luh KT. | Antimicrob Agents Chemother | 10.1128/aac.44.5.1342-1345.2000 | 2000 | |
| A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. | Chakravorty S, Helb D, Burday M, Connell N, Alland D. | J Microbiol Methods | 10.1016/j.mimet.2007.02.005 | 2007 | | |
| Pathogenicity | In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. | Barry AL, Fuchs PC, Brown SD. | Antimicrob Agents Chemother | 10.1128/aac.42.8.2138 | 1998 | |
| Pathogenicity | Comparison of agar dilution, broth dilution, and disk diffusion testing of ampicillin against Haemophilus species by using in-house and commercially prepared media. | Kohner PC, Rosenblatt JE, Cockerill FR. | J Clin Microbiol | 10.1128/jcm.32.6.1594-1596.1994 | 1994 | |
| Metabolism | In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase. | Tan CM, Gill CJ, Wu J, Toussaint N, Yin J, Tsuchiya T, Garlisi CG, Kaelin D, Meinke PT, Miesel L, Olsen DB, Lagrutta A, Fukuda H, Kishii R, Takei M, Oohata K, Takeuchi T, Shibue T, Takano H, Nishimura A, Fukuda Y, Singh SB. | Antimicrob Agents Chemother | 10.1128/aac.00619-16 | 2016 | |
| Pathogenicity | Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis. | Goldstein EJ, Citron DM, Merriam CV. | Antimicrob Agents Chemother | 10.1128/aac.43.3.705 | 1999 | |
| Metabolism | Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents. | Tari LW, Li X, Trzoss M, Bensen DC, Chen Z, Lam T, Zhang J, Lee SJ, Hough G, Phillipson D, Akers-Rodriguez S, Cunningham ML, Kwan BP, Nelson KJ, Castellano A, Locke JB, Brown-Driver V, Murphy TM, Ong VS, Pillar CM, Shinabarger DL, Nix J, Lightstone FC, Wong SE, Nguyen TB, Shaw KJ, Finn J. | PLoS One | 10.1371/journal.pone.0084409 | 2013 | |
| Pathogenicity | Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea. | Yum JH, Choi SH, Yong D, Chong Y, Im WB, Rhee DK, Lee K. | Antimicrob Agents Chemother | 10.1128/aac.00728-10 | 2010 | |
| A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012. | Cattoir V, Dowzicky MJ. | Antimicrob Resist Infect Control | 10.1186/2047-2994-3-36 | 2014 | | |
| Cultivation | Broth microdilution testing of Haemophilus influenzae with haemophilus test medium versus lysed horse blood broth. Canadian Haemophilus Study Group. | Scriver SR, Low DE, Simor AE, Toye B, McGeer A, Jaeger R. | J Clin Microbiol | 10.1128/jcm.30.9.2284-2289.1992 | 1992 | |
| Pathogenicity | Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). | Perez-Trallero E, Martin-Herrero JE, Mazon A, Garcia-Delafuente C, Robles P, Iriarte V, Dal-Re R, Garcia-de-Lomas J, Spanish Surveillance Group for Respiratory Pathogens. | Antimicrob Agents Chemother | 10.1128/aac.01548-09 | 2010 | |
| Pathogenicity | Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study Group. | Scriver SR, Walmsley SL, Kau CL, Hoban DJ, Brunton J, McGeer A, Moore TC, Witwicki E. | Antimicrob Agents Chemother | 10.1128/aac.38.7.1678 | 1994 | |
| Pathogenicity | In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea. | Yong DE, Cheong HJ, Kim YS, Park YJ, Kim WJ, Woo JH, Lee KW, Kang MW, Choo YS. | J Korean Med Sci | 10.3346/jkms.2002.17.6.737 | 2002 | |
| Pathogenicity | In vitro activities of piperacillin against beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. | Morikawa Y, Kitazato M, Mitsuyama J, Mizunaga S, Minami S, Watanabe Y. | Antimicrob Agents Chemother | 10.1128/aac.48.4.1229-1234.2004 | 2004 | |
| Rapid diagnosis of bacterial meningitis by real-time PCR and fluorescence in situ hybridization. | Poppert S, Essig A, Stoehr B, Steingruber A, Wirths B, Juretschko S, Reischl U, Wellinghausen N. | J Clin Microbiol | 10.1128/jcm.43.7.3390-3397.2005 | 2005 | | |
| National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study. | Critchley IA, Brown SD, Traczewski MM, Tillotson GS, Janjic N. | Antimicrob Agents Chemother | 10.1128/aac.00971-07 | 2007 | | |
| Pathogenicity | Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. | Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.00044-06 | 2006 | |
| Pathogenicity | Synergy of streptogramin antibiotics occurs independently of their effects on translation. | Noeske J, Huang J, Olivier NB, Giacobbe RA, Zambrowski M, Cate JH. | Antimicrob Agents Chemother | 10.1128/aac.03389-14 | 2014 | |
| Enzymology | Rapid identification of bacteria from positive blood cultures by terminal restriction fragment length polymorphism profile analysis of the 16S rRNA gene. | Christensen JE, Stencil JA, Reed KD. | J Clin Microbiol | 10.1128/jcm.41.8.3790-3800.2003 | 2003 | |
| Development of PCR assays to detect ampicillin resistance genes in cerebrospinal fluid samples containing Haemophilus influenzae. | Tenover FC, Huang MB, Rasheed JK, Persing DH. | J Clin Microbiol | 10.1128/jcm.32.11.2729-2737.1994 | 1994 | | |
| Enzymology | Rapid PCR detection of group A Streptococcus from flocked throat swabs: a retrospective clinical study. | Slinger R, Goldfarb D, Rajakumar D, Moldovan I, Barrowman N, Tam R, Chan F. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-10-33 | 2011 | |
| Pathogenicity | Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin. | Jorgensen JH, Maher LA, Howell AW. | Antimicrob Agents Chemother | 10.1128/aac.35.3.600 | 1991 | |
| Pathogenicity | Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999). | Gales A, Sader H, Jones RN, SENTRY Participants Group (Latin America). | Antimicrob Agents Chemother | 10.1128/aac.45.5.1463-1466.2001 | 2001 | |
| Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. | Campos J, Hernando M, Roman F, Perez-Vazquez M, Aracil B, Oteo J, Lazaro E, de Abajo F, Group of Invasive Haemophilus Infections of the Autonomous Community of Madrid, Spain,. | J Clin Microbiol | 10.1128/jcm.42.2.524-529.2004 | 2004 | | |
| Transfer of skin microbiota between two dissimilar autologous microenvironments: A pilot study. | Perin B, Addetia A, Qin X. | PLoS One | 10.1371/journal.pone.0226857 | 2019 | | |
| Pathogenicity | Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories. | Kiehlbauch JA, Hannett GE, Salfinger M, Archinal W, Monserrat C, Carlyn C. | J Clin Microbiol | 10.1128/jcm.38.9.3341-3348.2000 | 2000 | |
| Pathogenicity | Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. | Peric M, Bozdogan B, Jacobs MR, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.47.3.1017-1022.2003 | 2003 | |
| Pathogenicity | Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. | MacLeod DL, Barker LM, Sutherland JL, Moss SC, Gurgel JL, Kenney TF, Burns JL, Baker WR. | J Antimicrob Chemother | 10.1093/jac/dkp282 | 2009 | |
| Phylogeny | Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey. | Soyletir G, Altinkanat G, Gur D, Altun B, Tunger A, Aydemir S, Kayacan C, Aktas Z, Gunaydin M, Karadag A, Gorur H, Morrissey I, Torumkuney D. | J Antimicrob Chemother | 10.1093/jac/dkw075 | 2016 | |
| Phylogeny | Evaluation of methodology for serotyping invasive and nasopharyngeal isolates of Haemophilus influenzae in the ongoing surveillance in Brazil. | Bokermann S, Zanella RC, Lemos AP, de Andrade AL, Brandileone MC. | J Clin Microbiol | 10.1128/jcm.41.12.5546-5550.2003 | 2003 | |
| Enzymology | Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach. | Dumke R, Schurwanz N, Lenz M, Schuppler M, Luck C, Jacobs E. | J Clin Microbiol | 10.1128/jcm.00321-07 | 2007 | |
| Pathogenicity | In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. | Gunderson SM, Hayes RA, Quinn JP, Danziger LH. | Antimicrob Agents Chemother | 10.1128/aac.48.1.203-208.2004 | 2004 | |
| Enzymology | Novel antibacterial targets and compounds revealed by a high-throughput cell wall reporter assay. | Nayar AS, Dougherty TJ, Ferguson KE, Granger BA, McWilliams L, Stacey C, Leach LJ, Narita S, Tokuda H, Miller AA, Brown DG, McLeod SM. | J Bacteriol | 10.1128/jb.02552-14 | 2015 | |
| Pathogenicity | In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States. | Ge Y, Biek D, Talbot GH, Sahm DF. | Antimicrob Agents Chemother | 10.1128/aac.00149-08 | 2008 | |
| Growth and multiplexed analysis of microorganisms on a subdivided, highly porous, inorganic chip manufactured from anopore. | Ingham CJ, van den Ende M, Pijnenburg D, Wever PC, Schneeberger PM. | Appl Environ Microbiol | 10.1128/aem.71.12.8978-8981.2005 | 2005 | | |
| Pathogenicity | New class of competitive inhibitor of bacterial histidine kinases. | Gilmour R, Foster JE, Sheng Q, McClain JR, Riley A, Sun PM, Ng WL, Yan D, Nicas TI, Henry K, Winkler ME. | J Bacteriol | 10.1128/jb.187.23.8196-8200.2005 | 2005 | |
| Phylogeny | Evaluation of a rapid direct assay for identification of bacteria and the mec A and van genes from positive-testing blood cultures. | Eigner U, Weizenegger M, Fahr AM, Witte W. | J Clin Microbiol | 10.1128/jcm.43.10.5256-5262.2005 | 2005 | |
| Pathogenicity | Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases. | Stokes NR, Thomaides-Brears HB, Barker S, Bennett JM, Berry J, Collins I, Czaplewski LG, Gamble V, Lancett P, Logan A, Lunniss CJ, Peasley H, Pommier S, Price D, Smee C, Haydon DJ. | Antimicrob Agents Chemother | 10.1128/aac.00719-13 | 2013 | |
| Pathogenicity | Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. | Hasegawa K, Chiba N, Kobayashi R, Murayama SY, Iwata S, Sunakawa K, Ubukata K. | Antimicrob Agents Chemother | 10.1128/aac.48.5.1509-1514.2004 | 2004 | |
| The bioactivity of plant extracts against representative bacterial pathogens of the lower respiratory tract. | Bocanegra-Garcia V, Del Rayo Camacho-Corona M, Ramirez-Cabrera M, Rivera G, Garza-Gonzalez E. | BMC Res Notes | 10.1186/1756-0500-2-95 | 2009 | | |
| Development of a high throughput PCR to detect Coxiella burnetii and its application in a diagnostic laboratory over a 7-year period. | Jaton K, Peter O, Raoult D, Tissot JD, Greub G. | New Microbes New Infect | 10.1002/2052-2975.8 | 2013 | | |
| Enzymology | Microbiological evaluation of the new VITEK 2 Neisseria-Haemophilus identification card. | Valenza G, Ruoff C, Vogel U, Frosch M, Abele-Horn M. | J Clin Microbiol | 10.1128/jcm.00953-07 | 2007 | |
| Halophiles and Their Biomolecules: Recent Advances and Future Applications in Biomedicine. | Corral P, Amoozegar MA, Ventosa A. | Mar Drugs | 10.3390/md18010033 | 2019 | | |
| Enzymology | Comparison of DNA extraction methods for microbial community profiling with an application to pediatric bronchoalveolar lavage samples. | Willner D, Daly J, Whiley D, Grimwood K, Wainwright CE, Hugenholtz P. | PLoS One | 10.1371/journal.pone.0034605 | 2012 | |
| Pathogenicity | Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum. | Stein GE, Schooley S, Tyrrell KL, Citron DM, Goldstein EJ. | Antimicrob Agents Chemother | 10.1128/aac.47.4.1308-1312.2003 | 2003 | |
| Pathogenicity | Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates. | Jones RN, Fritsche TR, Sader HS. | Antimicrob Agents Chemother | 10.1128/aac.00294-08 | 2008 | |
| Pathogenicity | In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. | Brueggemann AB, Kugler KC, Doern GV. | Antimicrob Agents Chemother | 10.1128/aac.41.7.1594 | 1997 | |
| Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis. | Boving MK, Pedersen LN, Moller JK. | J Clin Microbiol | 10.1128/jcm.01966-08 | 2009 | | |
| Pathogenicity | In vitro activities of ABT-773, a new ketolide, against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis. | Goldstein EJ, Conrads G, Citron DM, Merriam CV, Warren Y, Tyrrell K. | Antimicrob Agents Chemother | 10.1128/aac.45.8.2363-2367.2001 | 2001 | |
| Pathogenicity | Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid. | Fuchs PC, Barry AL. | J Clin Microbiol | 10.1128/jcm.32.11.2846-2850.1994 | 1994 | |
| Pathogenicity | Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. | Baquero F, Garcia-Rodriguez JA, de Lomas JG, Aguilar L. | Antimicrob Agents Chemother | 10.1128/aac.43.1.178 | 1999 | |
| Metabolism | Evaluation of a FRET-peptide substrate to predict virulence in Pseudomonas aeruginosa. | Kaman WE, Arkoubi-El Arkoubi NE, Roffel S, Endtz HP, van Belkum A, Bikker FJ, Hays JP. | PLoS One | 10.1371/journal.pone.0081428 | 2013 | |
| Pathogenicity | Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). | Doern GV, Jones RN, Pfaller MA, Kugler K. | Antimicrob Agents Chemother | 10.1128/aac.43.2.385 | 1999 | |
| Pathogenicity | Comparison of broth microdilution method using Haemophilus test medium and agar dilution method for susceptibility testing of Eikenella corrodens. | Alcala L, Garcia-Garrote F, Cercenado E, Pelaez T, Ramos G, Bouza E. | J Clin Microbiol | 10.1128/jcm.36.8.2386-2388.1998 | 1998 | |
| Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. | Perez-Trallero E, Garcia-de-la-Fuente C, Garcia-Rey C, Baquero F, Aguilar L, Dal-Re R, Garcia-de-Lomas J, Spanish Surveillance Group for Respiratory Pathogens. | Antimicrob Agents Chemother | 10.1128/aac.49.5.1965-1972.2005 | 2005 | | |
| Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia. | Sader HS, Rhomberg PR, Farrell DJ, Jones RN. | Antimicrob Agents Chemother | 10.1128/aac.04839-14 | 2015 | | |
| Enzymology | Sensitivity and rapidity of blood culture bottles in the detection of cornea organ culture media contamination by bacteria and fungi. | Thuret G, Carricajo A, Chiquet C, Vautrin AC, Celle N, Boureille M, Acquart S, Aubert G, Maugery J, Gain P. | Br J Ophthalmol | 10.1136/bjo.86.12.1422 | 2002 | |
| Enzymology | New diagnostic real-time PCR for specific detection of Parachlamydia acanthamoebae DNA in clinical samples. | Casson N, Posfay-Barbe KM, Gervaix A, Greub G. | J Clin Microbiol | 10.1128/jcm.02302-07 | 2008 | |
| Pathogenicity | Activity of LBM415 compared to those of 11 other agents against Haemophilus species. | Bogdanovich T, Smith KA, Clark C, Pankuch GA, Lin G, McGhee P, Dewasse B, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.00106-06 | 2006 | |
| Pathogenicity | Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. | Baquero F, Garcia-Rodriguez JA, Garcia de Lomas J, Aguilar L. | Antimicrob Agents Chemother | 10.1128/aac.43.2.357 | 1999 | |
| Phylogeny | Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. | Roman F, Canton R, Perez-Vazquez M, Baquero F, Campos J. | J Clin Microbiol | 10.1128/jcm.42.4.1450-1459.2004 | 2004 | |
| Validation and reproducibility assessment of tigecycline MIC determinations by Etest. | Bolmstrom A, Karlsson A, Engelhardt A, Ho P, Petersen PJ, Bradford PA, Jones CH. | J Clin Microbiol | 10.1128/jcm.00089-07 | 2007 | | |
| Characteristics of pyogenic odontogenic infection in patients attending Mulago Hospital, Uganda: a cross-sectional study. | Kityamuwesi R, Muwaz L, Kasangaki A, Kajumbula H, Rwenyonyi CM. | BMC Microbiol | 10.1186/s12866-015-0382-z | 2015 | | |
| Pathogenicity | Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis. | Davies TA, Kelly LM, Hoellman DB, Ednie LM, Clark CL, Bajaksouzian S, Jacobs MR, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.44.3.633-639.2000 | 2000 | |
| Phylogeny | Detection of methicillin-resistant Staphylococcus aureus by a duplex droplet digital PCR assay. | Kelley K, Cosman A, Belgrader P, Chapman B, Sullivan DC. | J Clin Microbiol | 10.1128/jcm.00196-13 | 2013 | |
| Pathogenicity | In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens. | Lawrence L, Danese P, DeVito J, Franceschi F, Sutcliffe J. | Antimicrob Agents Chemother | 10.1128/aac.01383-07 | 2008 | |
| In vitro and In vivo activities of LB 10827, a new oral cephalosporin, against respiratory pathogens. | Paek KS, Kim MY, Lee CS, Youn H. | Antimicrob Agents Chemother | 10.1128/aac.44.12.3272-3277.2000 | 2000 | | |
| Low genetic diversity of Haemophilus influenzae type b compared to nonencapsulated H. influenzae in a population in which H. influenzae is highly endemic. | Smith-Vaughan HC, Sriprakash KS, Leach AJ, Mathews JD, Kemp DJ. | Infect Immun | 10.1128/iai.66.7.3403-3409.1998 | 1998 | | |
| Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models. | Li SA, Lee WH, Zhang Y. | Antimicrob Agents Chemother | 10.1128/aac.06304-11 | 2012 | | |
| Pathogenicity | First comprehensive evaluation of the M.I.C. evaluator device compared to Etest and CLSI reference dilution methods for antimicrobial susceptibility testing of clinical strains of anaerobes and other fastidious bacterial species. | Rennie RP, Turnbull L, Brosnikoff C, Cloke J. | J Clin Microbiol | 10.1128/jcm.05397-11 | 2012 | |
| Pathogenicity | Structure-guided discovery of novel aminoglycoside mimetics as antibacterial translation inhibitors. | Zhou Y, Gregor VE, Sun Z, Ayida BK, Winters GC, Murphy D, Simonsen KB, Vourloumis D, Fish S, Froelich JM, Wall D, Hermann T. | Antimicrob Agents Chemother | 10.1128/aac.49.12.4942-4949.2005 | 2005 | |
| Phylogeny | Protochlamydia naegleriophila as etiologic agent of pneumonia. | Casson N, Michel R, Muller KD, Aubert JD, Greub G. | Emerg Infect Dis | 10.3201/eid1401.070980 | 2008 | |
| Pathogenicity | Benzyl isothiocyanate, a major component from the roots of Salvadora persica is highly active against Gram-negative bacteria. | Sofrata A, Santangelo EM, Azeem M, Borg-Karlson AK, Gustafsson A, Putsep K. | PLoS One | 10.1371/journal.pone.0023045 | 2011 | |
| Pathogenicity | Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China. | Lin C, Li S, Sun H, Zhao H, Feng Y, Cao L, Yuan Y, Zhang T. | J Clin Microbiol | 10.1128/jcm.00400-10 | 2010 | |
| Pathogenicity | Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks. | Zerva L, Biedenbach DJ, Jones RN. | J Clin Microbiol | 10.1128/jcm.34.8.1970-1974.1996 | 1996 | |
| Enzymology | An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy. | Stokes NR, Baker N, Bennett JM, Berry J, Collins I, Czaplewski LG, Logan A, Macdonald R, Macleod L, Peasley H, Mitchell JP, Nayal N, Yadav A, Srivastava A, Haydon DJ. | Antimicrob Agents Chemother | 10.1128/aac.01580-12 | 2013 | |
| Enzymology | Rapid visual detection of highly pathogenic Streptococcus suis serotype 2 isolates by use of loop-mediated isothermal amplification. | Zhang J, Zhu J, Ren H, Zhu S, Zhao P, Zhang F, Lv H, Hu D, Hao L, Geng M, Gong X, Pan X, Wang C, Qi Z. | J Clin Microbiol | 10.1128/jcm.01183-13 | 2013 | |
| Pathogenicity | Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. | Kosowska K, Credito K, Pankuch GA, Hoellman D, Lin G, Clark C, Dewasse B, McGhee P, Jacobs MR, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.48.11.4113-4119.2004 | 2004 | |
| Pathogenicity | In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis. | Doern GV, Vautour R, Parker D, Tubert T, Torres B. | Antimicrob Agents Chemother | 10.1128/aac.35.7.1504 | 1991 | |
| Phylogeny | Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. | Sloan LM, Hopkins MK, Mitchell PS, Vetter EA, Rosenblatt JE, Harmsen WS, Cockerill FR, Patel R. | J Clin Microbiol | 10.1128/jcm.40.1.96-100.2002 | 2002 | |
| Pathogenicity | Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. | Doern GV, Brueggemann AB, Pierce G, Holley HP, Rauch A. | Antimicrob Agents Chemother | 10.1128/aac.41.2.292 | 1997 | |
| Pathogenicity | Disk diffusion versus broth microdilution susceptibility testing of Haemophilus species and Moraxella catarrhalis using seven oral antimicrobial agents: application of updated susceptibility guidelines of the National Committee for Clinical Laboratory Standards. | Kibsey PC, Rennie RP, Rushton JE. | J Clin Microbiol | 10.1128/jcm.32.11.2786-2790.1994 | 1994 | |
| Pathogenicity | Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents. | Credito KL, Lin G, Pankuch GA, Bajaksouzian S, Jacobs MR, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.45.1.67-72.2001 | 2001 | |
| Phylogeny | Rapid polymerase chain reaction-based screening assay for bacterial biothreat agents. | Yang S, Rothman RE, Hardick J, Kuroki M, Hardick A, Doshi V, Ramachandran P, Gaydos CA. | Acad Emerg Med | 10.1111/j.1553-2712.2008.00061.x | 2008 | |
| Pathogenicity | Pathogen-specific antimicrobials engineered de novo through membrane-protein biomimicry. | Simonson AW, Mongia AS, Aronson MR, Alumasa JN, Chan DC, Lawanprasert A, Howe MD, Bolotsky A, Mal TK, George C, Ebrahimi A, Baughn AD, Proctor EA, Keiler KC, Medina SH. | Nat Biomed Eng | 10.1038/s41551-020-00665-x | 2021 | |
| Pathogenicity | Stability of viable-bacterium counts in liquid media used for preparation of inocula and subsequent impact on antimicrobial susceptibility test results. | Hindler JA, Gonzalez AH, Drake TA. | J Clin Microbiol | 10.1128/jcm.28.6.1271-1275.1990 | 1990 | |
| Pathogenicity | Rational design of balanced dual-targeting antibiotics with limited resistance. | Nyerges A, Tomasic T, Durcik M, Revesz T, Szili P, Draskovits G, Bogar F, Skok Z, Zidar N, Ilas J, Zega A, Kikelj D, Daruka L, Kintses B, Vasarhelyi B, Foldesi I, Kata D, Welin M, Kimbung R, Focht D, Masic LP, Pal C. | PLoS Biol | 10.1371/journal.pbio.3000819 | 2020 | |
| Enzymology | Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR. | Geraats-Peters CW, Brouwers M, Schneeberger PM, van der Zanden AG, Bruisten SM, Weers-Pothoff G, Boel CH, van den Brule AJ, Harmsen HG, Hermans MH. | J Clin Microbiol | 10.1128/jcm.43.11.5653-5659.2005 | 2005 | |
| Variation in the composition and pore function of major outer membrane pore protein P2 of Haemophilus influenzae from cystic fibrosis patients. | Regelink AG, Dahan D, Moller LV, Coulton JW, Eijk P, Van Ulsen P, Dankert J, Van Alphen L. | Antimicrob Agents Chemother | 10.1128/aac.43.2.226 | 1999 | | |
| Pathogenicity | Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae. | Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Lin G, Felmingham D, Dencer C, Koeth L, Singer ME, Good CE. | J Clin Microbiol | 10.1128/jcm.40.9.3269-3276.2002 | 2002 | |
| Metabolic Profile, Bioactivities, and Variations in the Chemical Constituents of Essential Oils of the Ferula Genus (Apiaceae). | Sonigra P, Meena M. | Front Pharmacol | 10.3389/fphar.2020.608649 | 2020 | | |
| Pathogenicity | Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test. | Jorgensen JH, Howell AW, Maher LA. | J Clin Microbiol | 10.1128/jcm.29.1.109-114.1991 | 1991 | |
| Enzymology | Multiplex real-time PCR assay for rapid detection of methicillin-resistant staphylococci directly from positive blood cultures. | Wang HY, Kim S, Kim J, Park SD, Uh Y, Lee H. | J Clin Microbiol | 10.1128/jcm.00389-14 | 2014 | |
| Enzymology | Rapid identification of biothreat and other clinically relevant bacterial species by use of universal PCR coupled with high-resolution melting analysis. | Yang S, Ramachandran P, Rothman R, Hsieh YH, Hardick A, Won H, Kecojevic A, Jackman J, Gaydos C. | J Clin Microbiol | 10.1128/jcm.00033-09 | 2009 | |
| Rapid identification of bacterial pathogens in positive blood culture bottles by use of a broad-based PCR assay coupled with high-resolution melt analysis. | Won H, Rothman R, Ramachandran P, Hsieh YH, Kecojevic A, Carroll KC, Aird D, Gaydos C, Yang S. | J Clin Microbiol | 10.1128/jcm.00718-10 | 2010 | | |
| Pathogenicity | In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers. | Fuchs PC, Barry AL, Brown SD. | Antimicrob Agents Chemother | 10.1128/aac.42.5.1274 | 1998 | |
| Pathogenicity | Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. | Visser MR, Rozenberg-Arska M, Beumer H, Hoepelman IM, Verhoef J. | Antimicrob Agents Chemother | 10.1128/aac.35.5.858 | 1991 | |
| Pathogenicity | Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. | Mokaddas EM, Rotimi VO, Albert MJ. | Clin Vaccine Immunol | 10.1128/cvi.00277-07 | 2008 | |
| The vaginal microflora in relation to gingivitis. | Persson R, Hitti J, Verhelst R, Vaneechoutte M, Persson R, Hirschi R, Weibel M, Rothen M, Temmerman M, Paul K, Eschenbach D. | BMC Infect Dis | 10.1186/1471-2334-9-6 | 2009 | | |
| Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. | Clements JM, Beckett RP, Brown A, Catlin G, Lobell M, Palan S, Thomas W, Whittaker M, Wood S, Salama S, Baker PJ, Rodgers HF, Barynin V, Rice DW, Hunter MG. | Antimicrob Agents Chemother | 10.1128/aac.45.2.563-570.2001 | 2001 | | |
| Pathogenicity | In vitro activity of BAY 12-8039, a new fluoroquinolone. | Woodcock JM, Andrews JM, Boswell FJ, Brenwald NP, Wise R. | Antimicrob Agents Chemother | 10.1128/aac.41.1.101 | 1997 | |
| Pathogenicity | In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency. | Huband MD, Cohen MA, Meservey MA, Roland GE, Yoder SL, Dazer ME, Domagala JM. | Antimicrob Agents Chemother | 10.1128/aac.37.12.2563 | 1993 | |
| Pathogenicity | Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study. | Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch GA, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.43.8.1901 | 1999 | |
| Pathogenicity | Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States. | Jones ME, Staples AM, Critchley I, Thornsberry C, Heinze P, Engler HD, Sahm DF. | Antimicrob Agents Chemother | 10.1128/aac.44.10.2645-2652.2000 | 2000 | |
| In vitro antibacterial properties of pexiganan, an analog of magainin. | Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M. | Antimicrob Agents Chemother | 10.1128/aac.43.4.782 | 1999 | | |
| Pathogenicity | The antimicrobial potential of cannabidiol. | Blaskovich MAT, Kavanagh AM, Elliott AG, Zhang B, Ramu S, Amado M, Lowe GJ, Hinton AO, Pham DMT, Zuegg J, Beare N, Quach D, Sharp MD, Pogliano J, Rogers AP, Lyras D, Tan L, West NP, Crawford DW, Peterson ML, Callahan M, Thurn M. | Commun Biol | 10.1038/s42003-020-01530-y | 2021 | |
| Phylogeny | Analysis of mixed sequencing chromatograms and its application in direct 16S rRNA gene sequencing of polymicrobial samples. | Kommedal O, Karlsen B, Saebo O. | J Clin Microbiol | 10.1128/jcm.00213-08 | 2008 | |
| Pathogenicity | In vitro activity of Bay y 3118, a new quinolone. | Fass RJ. | Antimicrob Agents Chemother | 10.1128/aac.37.11.2348 | 1993 | |
| Evaluation of the analytical performance of the Xpert MTB/RIF assay. | Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, Chakravorty S, Jones M, Alland D. | J Clin Microbiol | 10.1128/jcm.00128-10 | 2010 | | |
| Pathogenicity | Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. | Thornsberry C, Ogilvie PT, Holley HP, Sahm DF. | Antimicrob Agents Chemother | 10.1128/aac.43.11.2612 | 1999 | |
| Enzymology | Optimal DNA isolation method for detection of bacteria in clinical specimens by broad-range PCR. | Rantakokko-Jalava K, Jalava J. | J Clin Microbiol | 10.1128/jcm.40.11.4211-4217.2002 | 2002 | |
| Current updates on oxazolidinone and its significance. | Pandit N, Singla RK, Shrivastava B. | Int J Med Chem | 10.1155/2012/159285 | 2012 | | |
| Pathogenicity | Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits. | Jorgensen JH, Doern GV, Ferraro MJ, Knapp CC, Swenson JM, Washington JA. | J Clin Microbiol | 10.1128/jcm.30.4.961-966.1992 | 1992 | |
| Discovery of a novel and potent class of FabI-directed antibacterial agents. | Payne DJ, Miller WH, Berry V, Brosky J, Burgess WJ, Chen E, DeWolf WE, Fosberry AP, Greenwood R, Head MS, Heerding DA, Janson CA, Jaworski DD, Keller PM, Manley PJ, Moore TD, Newlander KA, Pearson S, Polizzi BJ, Qiu X, Rittenhouse SF, Slater-Radosti C, Salyers KL, Seefeld MA, Smyth MG, Takata DT, Uzinskas IN, Vaidya K, Wallis NG, Winram SB, Yuan CC, Huffman WF. | Antimicrob Agents Chemother | 10.1128/aac.46.10.3118-3124.2002 | 2002 | | |
| Further studies on the application of vinylogous amides and beta-halovinylaldehydes to the regiospecific synthesis of unsymmetrical, polyfunctionalized 2,3,4- and 1,2,3,4- substituted pyrroles. | Gupton JT, Shimozono A, Crawford E, Ortolani J, Clark E, Mahoney M, Heese C, Noble J, Mandry CP, Kanters R, Dominey RN, Goldman EW, Sikorski JA, Fisher DC. | Tetrahedron | 10.1016/j.tet.2018.04.017 | 2018 | | |
| Pathogenicity | Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001. | Christiansen KJ, Bell JM, Turnidge JD, Jones RN. | Antimicrob Agents Chemother | 10.1128/aac.48.6.2049-2055.2004 | 2004 | |
| Pathogenicity | Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. | Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. | Antimicrob Agents Chemother | 10.1128/aac.40.4.891 | 1996 | |
| Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing. | Perez-Osorio AC, Boyle DS, Ingham ZK, Ostash A, Gautom RK, Colombel C, Houze Y, Leader BT. | J Clin Microbiol | 10.1128/jcm.05570-11 | 2012 | | |
| Pathogenicity | Antimicrobial susceptibility testing of less commonly isolated Haemophilus species using Haemophilus test medium. | Jorgensen JH, Howell AW, Maher LA. | J Clin Microbiol | 10.1128/jcm.28.5.985-988.1990 | 1990 | |
| Pathogenicity | Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. | Chongsiriwatana NP, Patch JA, Czyzewski AM, Dohm MT, Ivankin A, Gidalevitz D, Zuckermann RN, Barron AE. | Proc Natl Acad Sci U S A | 10.1073/pnas.0708254105 | 2008 | |
| Pathogenicity | Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study. | Berg HF, Tjhie JH, Scheffer GJ, Peeters MF, van Keulen PH, Kluytmans JA, Stobberingh EE. | Antimicrob Agents Chemother | 10.1128/aac.48.11.4183-4188.2004 | 2004 | |
| Enzymology | Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. | Roth A, Reischl U, Streubel A, Naumann L, Kroppenstedt RM, Habicht M, Fischer M, Mauch H. | J Clin Microbiol | 10.1128/jcm.38.3.1094-1104.2000 | 2000 | |
| Pathogenicity | Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98. | Doern GV, Brueggemann AB, Huynh H, Wingert E. | Emerg Infect Dis | 10.3201/eid0506.990603 | 1999 | |
| Longitudinal Assessment of Antimicrobial Susceptibility among Gram-Negative and Gram-Positive Organisms Collected from Italy as Part of the Tigecycline Evaluation and Surveillance Trial between 2004 and 2011. | Stefani S, Dowzicky MJ. | Pharmaceuticals (Basel) | 10.3390/ph6111381 | 2013 | | |
| Pathogenicity | IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. | Mosca DA, Hurst MA, So W, Viajar BS, Fujii CA, Falla TJ. | Antimicrob Agents Chemother | 10.1128/aac.44.7.1803-1808.2000 | 2000 | |
| Phylogeny | Heterogeneity of Actinobacillus actinomycetemcomitans strains in various human infections and relationships between serotype, genotype, and antimicrobial susceptibility. | Paju S, Carlson P, Jousimies-Somer H, Asikainen S. | J Clin Microbiol | 10.1128/jcm.38.1.79-84.2000 | 2000 | |
| Pathogenicity | Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. | Doern GV, Brueggemann A, Holley HP, Rauch AM. | Antimicrob Agents Chemother | 10.1128/aac.40.5.1208 | 1996 | |
| Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients. | Steinmann J, Giraud S, Schmidt D, Sedlacek L, Hamprecht A, Houbraken J, Meis JF, Bouchara JP, Buer J, Rath PM. | New Microbes New Infect | 10.1002/nmi2.44 | 2014 | | |
| Optimizing synthetic cystic fibrosis sputum media for growth of non-typeable Haemophilus influenzae. | Do Carmo Silva P, Hill D, Harrison F. | Access Microbiol | 10.1099/acmi.0.000979.v3 | 2025 | | |
| Gallium protoporphyrin as an antimicrobial for non-typeable Haemophilus influenzae in COPD patients. | Baker JM, Baba-Dikwa A, Shah R, Lea S, Singh D. | Life Sci | 10.1016/j.lfs.2022.120794 | 2022 | | |
| Differential responses of COPD macrophages to respiratory bacterial pathogens. | Lea S, Beech A, Baker J, Gaskell R, Pindolia D, Dikwa AB, Shah R, Singh D. | ERJ Open Res | 10.1183/23120541.00044-2022 | 2022 | | |
| Re-purposing of domestic steam disinfectors within the hospital-at-home setting. | Millar BC, Stirling J, Maguire M, Moore RE, Murphy A, Moore JE. | Infect Dis Health | 10.1016/j.idh.2020.09.005 | 2021 | | |
| Removal of Contaminant DNA by Combined UV-EMA Treatment Allows Low Copy Number Detection of Clinically Relevant Bacteria Using Pan-Bacterial Real-Time PCR. | Humphrey B, McLeod N, Turner C, Sutton JM, Dark PM, Warhurst G. | PLoS One | 10.1371/journal.pone.0132954 | 2015 | | |
| Endophytic Fungi from Alstonia boonei De Wild and Greenwayodendron suaveolens (Engl. and Diels) Verdc. subsp. Suaveolens Possess Inhibitory Activity against Pneumonia Causing Bacteria. | Demeni PCE, Betote PHD, Kom CW, Tchamgoue EN, Ndedi Moni EDF, Foumane Maniepi JS, Agbor GA, Nyegue MA | Evid Based Complement Alternat Med | 10.1155/2021/9966323 | 2021 | | |
| Antibacterial oral sprays from kaffir lime (Citrus hystrix DC.) fruit peel oil and leaf oil and their activities against respiratory tract pathogens. | Srifuengfung S, Bunyapraphatsara N, Satitpatipan V, Tribuddharat C, Junyaprasert VB, Tungrugsasut W, Srisukh V | J Tradit Complement Med | 10.1016/j.jtcme.2019.09.003 | 2019 | | |
| Cultivation | Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin. | Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP | J Clin Microbiol | 10.1128/JCM.00567-19 | 2019 | |
| Antibacterial, Antioxidant, and Antiproliferative Activities of Corymbia citriodora and the Essential Oils of Eight Eucalyptus Species. | Miguel MG, Gago C, Antunes MD, Lagoas S, Faleiro ML, Megias C, Cortes-Giraldo I, Vioque J, Figueiredo AC | Medicines (Basel) | 10.3390/medicines5030061 | 2018 | | |
| Pathogenicity | Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide. | Hackel MA, Karlowsky JA, Dressel D, Sahm DF | J Clin Microbiol | 10.1128/JCM.00972-17 | 2017 | |
| Pathogenicity | Implementation of the new VIRTUO blood culture system: evaluation and comparison to the 3D system using simulated blood cultures. | Miller N, Brassinne L, Allemeersch D | Acta Clin Belg | 10.1080/17843286.2017.1331618 | 2017 | |
| Metabolism | [Mouse macrophage-derived chemokine as an adjuvant enhances the protective effect of P6 protein vaccine of nontypeable Haemophilus influenzae]. | Han X, Wang C, Qiao H, Zhang Y, Chang Y, Zhang Y | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2014 | | |
| Pathogenicity | Determination of disk diffusion and MIC quality control guidelines for GSK2140944, a novel bacterial type II topoisomerase inhibitor antimicrobial agent. | Ross JE, Scangarella-Oman NE, Flamm RK, Jones RN | J Clin Microbiol | 10.1128/JCM.00656-14 | 2014 | |
| Pathogenicity | Activity of the antiseptic polyhexanide against gram-negative bacteria. | Fabry WH, Kock HJ, Vahlensieck W | Microb Drug Resist | 10.1089/mdr.2013.0113 | 2013 | |
| Pathogenicity | Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial. | Ross JE, Scangarella-Oman N, Jones RN | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2013.01.007 | 2013 | |
| Pathogenicity | Antimicrobial susceptibility testing of Streptococcus pneumoniae and Haemophilus influenzae --internal quality control as a quality tool on a national level. | Karpanoja P, Nissinen A, Huovinen P, Sarkkinen H | APMIS | 10.1111/apm.12021 | 2012 | |
| Pathogenicity | Antimicrobial and antioxidant properties of Betula aetnensis Rafin. (Betulaceae) leaves extract. | Acquaviva R, Menichini F, Ragusa S, Genovese C, Amodeo A, Tundis R, Loizzo MR, Iauk L | Nat Prod Res | 10.1080/14786419.2012.695364 | 2012 | |
| Pathogenicity | Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor. | Ross JE, Scangarella-Oman NE, Miller LA, Sader HS, Jones RN | J Clin Microbiol | 10.1128/JCM.01213-11 | 2011 | |
| Pathogenicity | Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone. | Ross JE, Liverman LC, Jones RN | J Clin Microbiol | 10.1128/JCM.00636-11 | 2011 | |
| Enzymology | [Cloning Hap gene from non-typeable Haemophilus influenzae and expression of Hap protein in prokaryotic cell]. | Li W, Kuang Y, Yao F, Yang Y, Chen C, Jiang Z, Li M | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | 2009 | | |
| Enzymology | [Species-identification and antimicrobial susceptibility tests by the fully automated RAISUS using an early-harvested cell suspension]. | Nakasone I, Kisanuki K, Higa M, Kinjo T, Yamane N | Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi | 2006 | | |
| Cultivation | Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control. | Brown SD, Traczewski MM | J Clin Microbiol | 10.1128/JCM.02351-06 | 2007 | |
| Pathogenicity | Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin. | Bouchillon SK, Johnson JL, Hoban DJ, Stevens TM, Johnson BM | J Antimicrob Chemother | 10.1093/jac/dki156 | 2005 | |
| Pathogenicity | Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitor. | Anderegg TR, Jones RN | Diagn Microbiol Infect Dis | 10.1016/S0732-8893(03)00162-7 | 2004 | |
| Pathogenicity | Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae. | Anderegg TR, Biedenbach DJ, Jones RN | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(03)00039-7 | 2003 | |
| Pathogenicity | Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756). | Hayashi K, Takahata M, Kawamura Y, Todo Y | Arzneimittelforschung | 10.1055/s-0031-1299988 | 2002 | |
| Phylogeny | Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. | Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, Pasquier C | Antimicrob Agents Chemother | 10.1128/AAC.46.7.2208-2218.2002 | 2002 | |
| Enzymology | Influence of CO(2) incubation on quinolone activity against Streptococcus pneumoniae and Haemophilus influenzae. | Bolmstrom A, Karlsson A | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(01)00338-8 | 2002 | |
| Pathogenicity | Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains. | Biedenbach DJ, Jones RN | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(01)00294-2 | 2001 | |
| Pathogenicity | Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001). | Jones RN, Biedenbach DJ | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(01)00236-x | 2001 | |
| Cultivation | Evaluation of quinupristin/dalfopristin (Synercid) and RPR 106972 stability in susceptibility testing media. | Marshall SA, Kugler KC, Jones RN | Int J Antimicrob Agents | 10.1016/s0924-8579(00)00180-1 | 2000 | |
| Phylogeny | Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae. | Jones RN, Biedenbach DJ, Erwin ME, Beach ML, Pfaller MA | J Clin Microbiol | 10.1128/JCM.37.6.1999-2002.1999 | 1999 | |
| Pathogenicity | Escherichia coli ATCC 35218 as a quality control isolate for susceptibility testing of Haemophilus influenzae with haemophilus test medium. | Butler DL, Jakielaszek CJ, Miller LA, Poupard JA | Antimicrob Agents Chemother | 10.1128/AAC.43.2.283 | 1999 | |
| Pathogenicity | Microbiologic effect of bovine cerebrospinal fluid and azithromycin against Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. | Destache CJ, Pakiz CB, Kersting K | Pharmacotherapy | 1997 | | |
| Pathogenicity | Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group. | Fuchs PC, Barry AL, Brown SD | J Clin Microbiol | 10.1128/jcm.35.1.125-131.1997 | 1997 | |
| Pathogenicity | Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628). | Sewell DL, Barry AL, Allen SD, Fuchs PC, Jorgensen JH, Tenover F | Diagn Microbiol Infect Dis | 10.1016/0732-8893(95)00021-2 | 1995 | |
| Pathogenicity | Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group. | Bale MJ, Jones RN, Erwin ME | Diagn Microbiol Infect Dis | 10.1016/0732-8893(94)90054-x | 1994 | |
| Pathogenicity | Agar disk diffusion (Bauer-Kirby) tests with various fastidious and nonfastidious reference (ATCC) strains: comparison of several agar media. | Traub WH, Leonhard B | Chemotherapy | 10.1159/000239296 | 1994 | |
| Pathogenicity | Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters. | Barry AL, Fuchs PC, Allen SD, Jorgensen JH, Tenover FC, Murray PR, Hardy DJ, Baker CN | J Clin Microbiol | 10.1128/jcm.31.9.2375-2380.1993 | 1993 | |
| Pathogenicity | Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests. | Barry AL, Fuchs PC, Jorgensen JH, Tenover FC, Allen SD, Hardy DJ, McLaughlin JC | J Clin Microbiol | 10.1128/jcm.31.3.751-753.1993 | 1993 | |
| Pathogenicity | Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin. | Barry AL, Jorgensen JH, Hardy DJ, Allen SD, Baker CN, Fuchs PC, McLaughlin JC | J Clin Microbiol | 10.1128/jcm.30.11.3013-3015.1992 | 1992 | |
| Cultivation | Performance of Haemophilus Test Media prepared with 12 different lots of Mueller-Hinton agar from four manufacturers. | Barry AL, Packer RR | J Clin Microbiol | 10.1128/jcm.30.5.1145-1147.1992 | 1992 | |
| Pathogenicity | Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin. | Bale MJ, Jones RN, Erwin ME, Koontz FP, Gerlach EH, Murray PR, Washington JA | J Clin Microbiol | 10.1128/jcm.30.3.744-745.1992 | 1992 | |
| Pathogenicity | Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium. | Pfaller MA, Jones RN, Washington JA, Koontz FP, Gerlach EH, Erwin ME | Diagn Microbiol Infect Dis | 10.1016/0732-8893(92)90039-v | 1992 | |
| Pathogenicity | MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin. | Bale MJ, Jones RN, Erwin ME, Koontz FP, Gerlach EH, Murray PR, Washington JA | J Clin Microbiol | 10.1128/jcm.30.1.225-226.1992 | 1992 | |
| Cultivation | Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium. | Doern GV, Gerlach EH, Jorgensen JH, Murray PR, Thornsberry C, Washington JA Jr | Diagn Microbiol Infect Dis | 10.1016/0732-8893(91)90004-y | 1991 | |
How to cite
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive11705.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain dataIsabel Schober, Julia Koblitz, Joaquim Sardà Carbasse, Christian Ebeling, Marvin Leon Schmidt, Adam Podstawka, Rohit Gupta, Vinodh Ilangovan, Javad Chamanara, Jörg Overmann, Lorenz Christian Reimer
Nucleic Acids Research; database issue 2025.
License